VISCERAL ADIPOSITY

/ DISEASE & DISORDERS, SCIENCE / By
  1. The perils of portliness: causes and consequences of Visceral Adiposity.
  2. The clinical importance of Visceral Adiposity: a critical review of methods for Visceral adipose tissue analysis
  3. Visceral Adiposity Index: a reliable indicator of Visceral fat function associated with cardiometabolic risk
  4. Visceral Adiposity syndrome
  5. Relationship of obesity and Visceral Adiposity with serum concentrations of CRP, TNF-α and IL-6
  6. Is Visceral Adiposity the “enemy within”?
  7. Point: Visceral Adiposity is causally related to insulin resistance
  8. Measures of abdominal obesity assessed for Visceral Adiposity and relation to coronary risk
  9. Visceral Adiposity and the risk of metabolic syndrome across body mass index: the MESA Study
  10. Sex differences in inflammatory markers: what is the contribution of Visceral Adiposity?
  11. Visceral Adiposity, insulin resistance and cancer risk
  12. Predictive performance of the Visceral Adiposity index for a Visceral Adiposity-related risk: type 2 diabetes
  13. Visceral Adiposity index: an indicator of adipose tissue dysfunction
  14. Visceral Adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.
  15. Visceral Adiposity as a target for the management of the metabolic syndrome
  16. Visceral Adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans
  17. Clinical significance of Visceral Adiposity assessed by computed tomography: a Japanese perspective
  18. Leptin selectively decreases Visceral Adiposity and enhances insulin action.
  19. Molecular evidence supporting the portal theory: a causative link between Visceral Adiposity and hepatic insulin resistance
  20. Visceral Adiposity is an independent predictor of incident hypertension in Japanese Americans
  21. Sleep apnoea and Visceral Adiposity in middle-aged male and female subjects
  22. Visceral Adiposity and the prevalence of hypertension in Japanese Americans
  23. Intestinal permeability is associated with Visceral Adiposity in healthy women
  24. The relationship between Visceral Adiposity and cognitive performance in older adults
  25. Cut-off points of the Visceral Adiposity index (VAI) identifying a Visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian …
  26. Adipocytokines attenuate the association between Visceral Adiposity and diabetes in older adults
  27. Maternal Visceral Adiposity by consistency of lactation
  28. Aortic stiffness is associated with Visceral Adiposity in older adults enrolled in the study of health, aging, and body composition
  29. Effect of growth hormone on body composition and Visceral Adiposity in middle-aged men with Visceral obesity
  30. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased Visceral Adiposity
  31. … between abdominal subcutaneous and Visceral Adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity …
  32. Effects of exercise intensity on cardiovascular fitness, total body composition, and Visceral Adiposity of obese adolescents
  33. Adipokines, inflammation, and Visceral Adiposity across the menopausal transition: a prospective study
  34. Effect of aerobic exercise training dose on liver fat and Visceral Adiposity
  35. Counterpoint: Visceral Adiposity is not causally related to insulin resistance
  36. Adiponectin in youth: relationship to Visceral Adiposity, insulin sensitivity, and β-cell function
  37. Relationship between Visceral Adiposity and bone mineral density in Korean adults
  38. Visceral Adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels
  39. Visceral Adiposity is associated with serum retinol binding protein‐4 levels in healthy women
  40. The Visceral Adiposity syndrome in Japanese‐American men
  41. Asian women have greater abdominal and Visceral Adiposity than Caucasian women with similar body mass index
  42. Gender‐specific anthropometric markers of Adiposity, metabolic syndrome and Visceral Adiposity index (VAI) in patients with obstructive sleep apnea
  43. Relationship of Visceral Adiposity to cardiovascular disease risk factors in black and white teens
  44. Fructose consumption: potential mechanisms for its effects to increase Visceral Adiposity and induce dyslipidemia and insulin resistance
  45. Dysregulation of the autonomic nervous system can be a link between Visceral Adiposity and insulin resistance
  46. An open-label pilot study to assess the efficacy and safety of virgin coconut oil in reducing Visceral Adiposity
  47. Rapid postnatal weight gain and Visceral Adiposity in adulthood: the Fels Longitudinal Study
  48. Visceral Adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans
  49. Age-related differences in inflammatory markers in men: contribution of Visceral Adiposity
  50. Sarcopenia, intramuscular fat deposition, and Visceral Adiposity independently predict the outcomes of hepatocellular carcinoma
  51. The application of Visceral Adiposity index in identifying type 2 diabetes risks based on a prospective cohort in China
  52. Visceral Adiposity is negatively associated with bone density and muscle attenuation
  53. Visceral Adiposity in gastrointestinal and hepatic carcinogenesis
  54. … Visceral Adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and Visceral …
  55. Ten months of exercise improves general and Visceral Adiposity, bone, and fitness in black girls
  56. Testosterone replacement therapy improves insulin resistance, glycaemic control, Visceral Adiposity and hypercholesterolaemia in hypogonadal men with …
  57. Visceral Adiposity without overweight in children born small for gestational age
  58. Visceral Adiposity index (VAI) is predictive of an altered adipokine profile in patients with type 2 diabetes
  59. Systemic oxidative alterations are associated with Visceral Adiposity and liver steatosis in patients with metabolic syndrome
  60. Central obesity as a clinical marker of adiposopathy; increased Visceral Adiposity as a surrogate marker for global fat dysfunction
  61. Genetic epidemiology of insulin resistance and Visceral Adiposity: the IRAS Family Study design and methods
  62. Visceral Adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community …
  63. Visceral Adiposity index is associated with significant fibrosis in patients with non‐alcoholic fatty liver disease
  64. The Visceral Adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome
  65. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, Visceral Adiposity, and insulin resistance?
  66. Dietary determinants of changes in waist circumference adjusted for body mass index–a proxy measure of Visceral Adiposity
  67. Usefulness of measuring both body mass index and waist circumference for the estimation of Visceral Adiposity and related cardiometabolic risk profile (from the …
  68. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low Visceral Adiposity
  69. White blood cell count in women: relation to inflammatory biomarkers, haematological profiles, Visceral Adiposity, and other cardiovascular risk factors
  70. Visceral Adiposity index is highly associated with adiponectin values and glycaemic disturbances
  71. Association of lifestyle factors with abdominal subcutaneous and Visceral Adiposity: the Framingham Heart Study
  72. Greater fructose consumption is associated with cardiometabolic risk markers and Visceral Adiposity in adolescents
  73. Breastfeeding and subsequent maternal Visceral Adiposity
  74. Adverse associations between Visceral Adiposity, brain structure, and cognitive performance in healthy elderly
  75. Visceral Adiposity is closely correlated with neck circumference and represents a significant indicator of insulin resistance in WHO grade III obesity
  76. Visceral Adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1
  77. General and Visceral Adiposity in black and white adolescents and their relation with reported physical activity and diet
  78. Applicability of the Visceral Adiposity index (VAI) in predicting components of metabolic syndrome in young adults
  79. In vivo quantification of subcutaneous and Visceral Adiposity by micro-computed tomography in a small animal model
  80. Consuming fructose-sweetened, not glucose-sweetened, beverages increases Visceral Adiposity and lipids and decreases insulin sensitivity in overweight …
  81. Visceral Adiposity index may be a surrogate marker for the assessment of the effects of obesity on arterial stiffness
  82. Change in Visceral Adiposity independently predicts a greater risk of developing type 2 diabetes over 10 years in Japanese Americans
  83. Visceral Adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome
  84. 4-year trajectory of Visceral Adiposity index in the development of type 2 diabetes: a prospective cohort study
  85. Inverse relation between dietary fiber intake and Visceral Adiposity in overweight Latino youth
  86. The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high Visceral Adiposity index: a likely condition of cardiometabolic risk
  87. Abdominal Visceral Adiposity in the first trimester predicts glucose intolerance in later pregnancy
  88. Uteroplacental insufficiency increases Visceral Adiposity and Visceral adipose PPARγ2 expression in male rat offspring prior to the onset of obesity
  89. Association of subcutaneous and Visceral Adiposity with albuminuria: the Framingham Heart Study
  90. Visceral Adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS
  91. Quantitative measures of Visceral Adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation
  92. Echocardiographic assessment of epicardial adipose tissue-a marker of Visceral Adiposity
  93. Adipose tissue gene expression profiling reveals distinct molecular pathways that define Visceral Adiposity in offspring of maternal protein-restricted rats
  94. Inflammation mediates the association between Visceral Adiposity and obstructive sleep apnea in adolescents
  95. Identification of cardiometabolic risk: Visceral Adiposity index versus triglyceride/HDL cholesterol ratio
  96. Clinical usefulness of lipid ratios, Visceral Adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance
  97. Visceral Adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients
  98. Predictive value of Visceral Adiposity index for type 2 diabetes mellitus
  99. Lower growth hormone and higher cortisol are associated with greater Visceral Adiposity, intramyocellular lipids, and insulin resistance in overweight girls
  100. Earlier appearance of impaired insulin secretion than of Visceral Adiposity in the pathogenesis of NIDDM: 5-year follow-up of initially nondiabetic Japanese-American …
  101. Exposure to persistent organic pollutants: relationship with abnormal glucose metabolism and Visceral Adiposity
  102. Heart rate variability in obese children: relations to total body and Visceral Adiposity, and changes with physical training and detraining
  103. Erectile dysfunction is associated with low bioactive testosterone levels and Visceral Adiposity in men with type 2 diabetes
  104. Relationship between Visceral Adiposity and intramyocellular lipid content in two rat models of insulin resistance
  105. Association of Visceral Adiposity with oesophageal and junctional adenocarcinomas
  106. Applicatility of the Visceral Adiposity index (VAI) in the prediction of the components of the metabolic syndrome in elderly
  107. Does insulin resistance, Visceral Adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women
  108. Significantly increased Visceral Adiposity index in prehypertension
  109. Visceral Adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients
  110. RAAS activation is associated with Visceral Adiposity and insulin resistance among HIV-infected patients
  111. Depressive symptoms are associated with Visceral Adiposity in a community‐based sample of middle‐aged women and men
  112. Visceral Adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009
  113. Elevated fasting plasma ghrelin in Prader-Willi syndrome adults is not solely explained by their reduced Visceral Adiposity and insulin resistance
  114. Associations of Visceral Adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults
  115. Relation of Visceral Adiposity to circulating natriuretic peptides in ambulatory individuals
  116. Are general obesity and Visceral Adiposity in men linked to reduced bone mineral content resulting from normal ageing? A population‐based study
  117. Association of abdominal Visceral Adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients
  118. Waist circumference measurement site does not affect relationships with Visceral Adiposity and cardiometabolic risk factors in children
  119. Visceral Adiposity index is associated with pre-diabetes and type 2 diabetes mellitus in Chinese adults aged 20-50
  120. Visceral Adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large …
  121. Olanzapine-induced weight gain and increased Visceral Adiposity is blocked by melatonin replacement therapy in rats
  122. Visceral Adiposity and left ventricular remodeling: the Multi-Ethnic Study of Atherosclerosis
  123. Prognostic significance of the complex” Visceral Adiposity index” vs. simple anthropometric measures: Tehran lipid and glucose study
  124. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and Visceral Adiposity
  125. Association of serum retinol-binding protein 4 and Visceral Adiposity in Chinese subjects with and without type 2 diabetes
  126. Dietary chickpeas reverse Visceral Adiposity, dyslipidaemia and insulin resistance in rats induced by a chronic high-fat diet
  127. Impact of body mass index and Visceral Adiposity on outcomes in colorectal cancer
  128. Aerobic plus resistance training was more effective in improving the Visceral Adiposity, metabolic profile and inflammatory markers than aerobic training in obese …
  129. Chronic maternal dietary chromium restriction modulates Visceral Adiposity: probable underlying mechanisms
  130. Visceral Adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease
  131. Low cardiorespiratory fitness levels and elevated blood pressure: what is the contribution of Visceral Adiposity?
  132. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, Visceral Adiposity, and hypoadiponectinemia in …
  133. Visceral Adiposity and colorectal adenomas: dose-response meta-analysis of observational studies
  134. Visceral Adiposity is a risk factor for poor prognosis in colorectal cancer patients receiving adjuvant chemotherapy
  135. Peripheral, but not central, administration of adiponectin reduces Visceral Adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese …
  136. Significant correlation between Visceral Adiposity and high-sensitivity C-reactive protein (hs-CRP) in Japanese subjects
  137. Indirect measure of Visceral Adiposity ‘A Body Shape Index'(ABSI) is associated with arterial stiffness in patients with type 2 diabetes
  138. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: its relationships with body fat, Visceral Adiposity, and age in women
  139. Sleep-disordered breathing in obese adolescents is associated with Visceral Adiposity and markers of insulin resistance
  140. A thyroid hormone receptor α gene mutation (P398H) is associated with Visceral Adiposity and impaired catecholamine-stimulated lipolysis in mice
  141. Stop feeding cancer: pro-inflammatory role of Visceral Adiposity in liver cancer
  142. Changes in both global diet quality and physical activity level synergistically reduce Visceral Adiposity in men with features of metabolic syndrome
  143. Improved insulin sensitivity despite increased Visceral Adiposity in mice deficient for the immune cell transcription factor T-bet
  144. Sagittal abdominal diameter and Visceral Adiposity
  145. Visceral Adiposity, increased adipocyte lipolysis, and metabolic dysfunction in obese postmenopausal women
  146. Hyperleptinemia, Visceral Adiposity, and decreased glucose tolerance in mice with a targeted disruption of the histidine decarboxylase gene
  147. The relationship between “food addiction” and Visceral Adiposity in young females
  148. Functional variation in the androgen-receptor gene is associated with Visceral Adiposity and blood pressure in male adolescents
  149. FFAs and QT intervals in obese women with Visceral Adiposity: effects of sustained weight loss over 1 year
  150. Visceral Adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1
  151. Visceral Adiposity and risk of coronary heart disease in relatively lean Chinese adults
  152. Dietary predictors of Visceral Adiposity in overweight young adults
  153. Dietary determinants of hepatic steatosis and Visceral Adiposity in overweight and obese youth at risk of type 2 diabetes
  154. Central pro-opiomelanocortin gene delivery results in hypophagia, reduced Visceral Adiposity, and improved insulin sensitivity in genetically obese Zucker rats
  155. Visceral Adiposity and endothelial lipase
  156. Garcinia cambogia extract ameliorates Visceral Adiposity in C57BL/6J mice fed on a high-fat diet
  157. Lipid accumulation product and Visceral Adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype
  158. Serum levels of pigment epithelium‐derived factor (PEDF) are positively associated with Visceral Adiposity in Japanese patients with type 2 diabetes
  159. Insulin resistance, beta cell dysfunction and Visceral Adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family …
  160. Visceral Adiposity, fasting plasma insulin, and blood pressure in Japanese-Americans
  161. Constant light induces alterations in melatonin levels, food intake, feed efficiency, Visceral Adiposity, and circadian rhythms in rats
  162. Visceral Adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome
  163. Lifestyle intervention involving calorie restriction with or without aerobic exercise training improves liver fat in adults with Visceral Adiposity
  164. Hepatic steatosis rather than Visceral Adiposity is more closely associated with insulin resistance in the early stage of obesity
  165. High-fructose diet leads to Visceral Adiposity and hypothalamic leptin resistance in male rats—do glucocorticoids play a role?
  166. Unique profile of chicken adiponectin, a predominantly heavy molecular weight multimer, and relationship to Visceral Adiposity
  167. Visceral Adiposity in persons with chronic spinal cord injury determined by dual energy X‐ray absorptiometry
  168. Visceral Adiposity index and lipid accumulation product index: two alternate body indices to identify chronic kidney disease among the rural population in Northeast …
  169. Measures of body Adiposity and Visceral Adiposity index as predictors of metabolic syndrome among Thai women with PCOS
  170. Short‐term melatonin consumption protects the heart of obese rats independent of body weight change and Visceral Adiposity
  171. Visceral Adiposity and left ventricular mass and function in patients with aortic stenosis: the PROGRESSA study
  172. Increased Visceral Adiposity is associated with coronary artery calcification in male patients with chronic kidney disease
  173. The Visceral Adiposity index in comparison with easily measurable anthropometric markers did not improve prediction of diabetes
  174. Effect of orlistat alone or in combination with Garcinia cambogia on Visceral Adiposity index in obese patients
  175. Significant associations of age, menopausal status and lifestyle factors with Visceral Adiposity in African-American and European-American women
  176. Combination therapy with naltrexone and bupropion for obesity reduces total and Visceral Adiposity
  177. The relationship between Visceral Adiposity and left ventricular diastolic function: results from the Baltimore Longitudinal Study of Aging
  178. Relationships between exercise-induced reductions in thigh intermuscular adipose tissue, changes in lipoprotein particle size, and Visceral Adiposity
  179. Impact of Visceral Adiposity measured by abdominal computed tomography on pulmonary function
  180. Impact of increased Visceral Adiposity with normal weight on the progression of arterial stiffness in Japanese patients with type 2 diabetes
  181. Visceral Adiposity and anthropometric indicators as screening tools of metabolic syndrome among low income rural adults in Xinjiang
  182. Visceral Adiposity and cardiometabolic risks: epidemic of abdominal obesity in North America
  183. The Visceral Adiposity index: Relationship with cardiometabolic risk factors in obese and overweight postmenopausal women–A MONET group study
  184. Anthropometric predictors of Visceral Adiposity in normal‐weight and obese adolescents
  185. Higher intake of PUFAs is associated with lower total and Visceral Adiposity and higher lean mass in a racially diverse sample of children
  186. Contribution of Visceral Adiposity to the exaggerated postprandial lipemia of men with impaired glucose tolerance
  187. Applicability of Visceral Adiposity index in predicting metabolic syndrome in adults with obstructive sleep apnea: a cross-sectional study
  188. Increased Visceral Adiposity and cortisol to cortisone ratio in adults with congenital lifetime isolated GH deficiency
  189. Intramyocellular lipid is associated with Visceral Adiposity, markers of insulin resistance, and cardiovascular risk in prepubertal children: the EPOCH study
  190. Age-related changes in basal substrate oxidation and Visceral Adiposity and their association with metabolic syndrome
  191. Visceral Adiposity index and insulin secretion and action in first‐degree relatives of subjects with type 2 diabetes
  192. Eight weeks of a combination of high intensity interval training and conventional training reduce Visceral Adiposity and improve physical fitness: a group-based …
  193. Constitutive adipocyte mTORC1 activation enhances mitochondrial activity and reduces Visceral Adiposity in mice
  194. The relationship between Visceral Adiposity and the risk of erosive esophagitis in severely obese Chinese patients
  195. Visceral Adiposity, insulin resistance, and type 2 diabetes
  196. Decreased Visceral Adiposity accounts for leptin effect on hepatic but not peripheral insulin action
  197. Visceral Adiposity index score indicated the severity of coronary heart disease in Chinese adults
  198. Visceral Adiposity in the first half of pregnancy predicts newborn weight among adolescent mothers
  199. Association between birth weight and insulin sensitivity in healthy young men in Korea: role of Visceral Adiposity
  200. … lower sex hormone binding globulin and higher dehydroepiandrosterone sulfate levels and aggravate their Visceral Adiposity and hypoadiponectinemia between six …
  201. Association of dietary factors with abdominal subcutaneous and Visceral Adiposity in Japanese men
  202. Comparative relation of general, central, and Visceral Adiposity measures for coronary artery calcium in subjects without previous coronary events
  203. Left ventricular structure and function in obese adolescents: relations to cardiovascular fitness, percent body fat, and Visceral Adiposity, and effects of physical training
  204. Association between Visceral Adiposity and colorectal polyps on CT colonography
  205. Visceral Adiposity, not abdominal subcutaneous fat area, is associated with high blood pressure in Japanese men: the Ohtori study
  206. Combined impact of cardiorespiratory fitness and Visceral Adiposity on metabolic syndrome in overweight and obese adults in Korea
  207. Oleuropein attenuates Visceral Adiposity in high‐fat diet‐induced obese mice through the modulation of WNT10b‐and galanin‐mediated signalings
  208. Aerobic exercise attenuates the loss of skeletal muscle during energy restriction in adults with Visceral Adiposity
  209. Visceral Adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension
  210. Low birth weight male guinea pig offspring display increased Visceral Adiposity in early adulthood
  211. Contributions of cardiorespiratory fitness and Visceral Adiposity to six-year changes in cardiometabolic risk markers in apparently healthy men and women
  212. Visceral Adiposity and subclinical coronary artery disease in elderly adults: Rancho Bernardo Study
  213. Volume-dependent effect of supervised exercise training on fatty liver and Visceral Adiposity index in subjects with type 2 diabetes The Italian Diabetes Exercise Study …
  214. … Insulin resistance, in obese and non obese, diabetics and non diabetics: A cross sectional observational study.(Mysore Visceral Adiposity in Diabetes Study)
  215. Maternal X chromosome, Visceral Adiposity, and lipid profile
  216. PDE5 inhibition ameliorates Visceral Adiposity targeting the miR-22/SIRT1 pathway: evidence from the CECSID trial
  217. Sedentariness and increased Visceral Adiposity in adult perinatally iron-deficient rats
  218. Role of the insulin-like growth factor 1 axis and Visceral Adiposity in oesophageal adenocarcinoma
  219. Epicardial adipose tissue is related to carotid intima-media thickness and Visceral Adiposity in HIV-infected patients with highly active antiretroviral therapy-associated …
  220. Insulin, C-peptide, and leptin concentrations predict increased Visceral Adiposity at 5-and 10-year follow-ups in nondiabetic Japanese Americans
  221. Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients
  222. Visceral Adiposity is preferentially associated with vascular stiffness rather than thickness in men with type 2 diabetes
  223. Visceral Adiposity index and prognosis among patients with ischemic heart failure
  224. Influence of high-normal serum TSH levels on major cardiovascular risk factors and Visceral Adiposity Index in euthyroid type 2 diabetic subjects
  225. The heme oxygenase system suppresses perirenal Visceral Adiposity, abates renal inflammation and ameliorates diabetic nephropathy in Zucker diabetic fatty …
  226. Visceral Adiposity, androgens, and plasma lipids in obese men
  227. Visceral Adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome
  228. Visceral Adiposity is not associated with abdominal aortic aneurysm presence and growth
  229. Visceral Adiposity is associated with cytokines and decrease in lung function in women with persistent asthma
  230. Visceral Adiposity is associated with SIRT1 expression in peripheral blood mononuclear cells: a pilot study
  231. Apolipoprotein A‐II polymorphism and Visceral Adiposity in African‐American and white women
  232. Autocrine function of aldehyde dehydrogenase 1 as a determinant of diet-and sex-specific differences in Visceral Adiposity
  233. Does Visceral Adiposity index signify early metabolic risk in children and adolescents?: association with insulin resistance, adipokines, and subclinical …
  234. Nontraditional risk factors for cardiovascular disease and Visceral Adiposity index among different body size phenotypes
  235. Reduction in Visceral Adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin
  236. Visceral Adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients
  237. The contribution of Visceral Adiposity and mid‐thigh fat‐rich muscle to the metabolic profile in postmenopausal women
  238. Visceral Adiposity, fasting plasma insulin, and lipid and lipoprotein levels in Japanese Americans.
  239. Changes in Visceral Adiposity and serum cholesterol with a novel viscous polysaccharide in Japanese adults with abdominal obesity
  240. Treatment with a SOD mimetic reduces Visceral Adiposity, adipocyte death, and adipose tissue inflammation in high fat‐fed mice
  241. Increased risk of subclinical atherosclerosis associated with high Visceral Adiposity index in apparently healthy Korean adults: the Kangbuk Samsung Health Study
  242. Contribution of Visceral Adiposity and insulin resistance to metabolic risk factors in Japanese men
  243. Novel genes of Visceral Adiposity: identification of mouse and human mesenteric estrogen-dependent adipose (MEDA)-4 gene and its adipogenic function
  244. Troglitazone prevents the rise in Visceral Adiposity and improves fatty liver associated with sulfonylurea therapy—a randomized controlled trial
  245. Brown fat lipoatrophy and increased Visceral Adiposity through a concerted adipocytokines overexpression induces vascular insulin resistance and dysfunction
  246. Plasma soluble tumour necrosis factor‐α receptor 2 is elevated in obesity: specific contribution of Visceral Adiposity
  247. Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with Visceral Adiposity and metabolic syndrome in humans
  248. Liver fat, Visceral Adiposity, and sleep disturbances contribute to the development of insulin resistance and glucose intolerance in nondiabetic dialysis patients
  249. Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not Visceral Adiposity index, in severely obese patients
  250. Insulin resistance but not Visceral Adiposity index is associated with liver fibrosis in nondiabetic subjects with nonalcoholic fatty liver disease
  251. Alteration of the growth hormone axis, Visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the Visceral Adiposity index
  252. Apolipoprotein B/A1 ratio is associated with free androgen index and Visceral Adiposity and may be an indicator of metabolic syndrome in male children and …
  253. … in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, Visceral Adiposity, insulin sensitivity, and …
  254. An acylic polyisoprenoid derivative, geranylgeranylacetone protects against Visceral Adiposity and insulin resistance in high-fat-fed mice
  255. Visceral Adiposity is associated with an increased risk of functional dyspepsia
  256. Is there a role for Visceral Adiposity in inducing type 2 diabetes remission in severely obese patients following biliopancreatic diversion with duodenal switch surgery?
  257. Visceral Adiposity is associated with increased lipid oxidation in obese, postmenopausal women
  258. Objectively quantified physical activity and sedentary behavior in predicting Visceral Adiposity and liver fat
  259. Mild electrical stimulation with heat shock reduces Visceral Adiposity and improves metabolic abnormalities in subjects with metabolic syndrome or type 2 …
  260. Common variants near melanocortin 4 receptor are associated with general and Visceral Adiposity in European-and African-American youth
  261. Gonadal failure is associated with Visceral Adiposity in myotonic dystrophies
  262. Late gestation over‐and undernutrition predispose for Visceral Adiposity in response to a post‐natal obesogenic diet, but with differential impacts on glucose–insulin …
  263. Low insulin secretion and high fasting insulin and C-peptide levels predict increased Visceral Adiposity: 5-year follow-up among initially nondiabetic Japanese …
  264. Association of nonalcoholic fatty liver disease with Visceral Adiposity but not coronary artery calcification in the elderly
  265. Association of dietary proportions of macronutrients with Visceral Adiposity index: non-substitution and iso-energetic substitution models in a prospective study
  266. The impact of blood pressure and Visceral Adiposity on the association of serum uric acid with albuminuria in adults without full metabolic syndrome
  267. Hepatic fat content-independent association of the serum level of gamma-glutamyltransferase with Visceral Adiposity, but not subcutaneous Adiposity
  268. Visceral Adiposity is associated with altered myocardial glucose uptake measured by 18 FDG-PET in 346 subjects with normal glucose tolerance, prediabetes …
  269. Metformin therapy to reduce weight gain and Visceral Adiposity in children and adolescents with neurogenic or myogenic motor deficit
  270. Causes and consequences of human variation in Visceral Adiposity
  271. Excess Visceral Adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma
  272. Dietary vitamin A and Visceral Adiposity: a modulating role of the retinol-binding protein 4 gene
  273. Visceral Adiposity index, hypertriglyceridemic waist phenotype and chronic kidney disease in a southern Chinese population: a cross-sectional study
  274. Reduction of Visceral Adiposity after operation in a subject with insulinoma
  275. Visceral Adiposity and skeletal muscle mass are independently and synergistically associated with left ventricular structure and function: the Korean Genome and …
  276. Reversal of Visceral Adiposity in candy-diet fed female Wistar rats by the CB1 receptor antagonist rimonabant
  277. Hyperhomocysteinemia is associated with Visceral Adiposity in Japanese patients with type 2 diabetes mellitus
  278. Visceral Adiposity and subclinical atherosclerosis in healthy young men
  279. Visceral Adiposity in the first half of pregnancy in association with glucose, lipid and insulin profiles in later pregnancy: a cohort study
  280. Association of breastfeeding with postmenopausal Visceral Adiposity among three racial/ethnic groups
  281. Correlation of renin angiotensin and aldosterone system activity with subcutaneous and Visceral Adiposity: the framingham heart study
  282. Visceral Adiposity is not associated with inflammatory markers in trauma patients
  283. A pilot study of telmisartan for Visceral Adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial
  284. Impaired growth hormone secretion correlates with Visceral Adiposity in highly active antiretroviral treated HIV-infected adolescents
  285. Is Visceral Adiposity a significant correlate of subcutaneous adipose cell lipolysis in men?
  286. Higher Visceral Adiposity is associated with an enhanced early thermogenic response to carbohydrate-rich food
  287. Visceral Adiposity is a predictor of parathyroid hormone levels in healthy adults
  288. Prunus mume and Lithospermum erythrorhizon extracts synergistically prevent Visceral Adiposity by improving energy metabolism through potentiating …
  289. Increased Visceral Adiposity with normal weight is associated with the prevalence of non‐alcoholic fatty liver disease in Japanese patients with type 2 diabetes
  290. Cut-off values of Visceral Adiposity to predict NAFLD in Brazilian obese adolescents
  291. Flavonoid-rich Chardonnay grape seed flour supplementation ameliorates diet-induced Visceral Adiposity, insulin resistance, and glucose intolerance via altered …
  292. Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat Visceral Adiposity and hyperleptinemia in type 2 diabetic Goto …
  293. … of Visceral Adiposity index with chronic kidney disease in the People’s Republic of China: to rediscover the new clinical potential of an old indicator for Visceral …
  294. Carotid atherosclerosis mediated by Visceral Adiposity and adipocytokines in type 2 diabetic subjects
  295. Visceral Adiposity in young patients with coronary artery disease—a case control study
  296. Tonsil-derived mesenchymal stem cells promote bone mineralization and reduce marrow and Visceral Adiposity in a mouse model of senile osteoporosis
  297. Long-term risperidone treatment induces Visceral Adiposity associated with hepatic steatosis in mice: a magnetic resonance approach
  298. Sleep and birthweight predict Visceral Adiposity in overweight/obese children
  299. Normalization of Visceral Adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification …
  300. Novel gender-specific Visceral Adiposity index for Mexican pediatric population
  301. The efficiency of cavitation ultrasound therapy on Visceral Adiposity in perimenpausal women
  302. Distinctive inhibitory mechanisms of age and relative Visceral Adiposity on growth hormone secretion in pre-and postmenopausal women studied under a …
  303. Visceral Adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia
  304. Proteomics and genomics: A hypothesis‐free approach to the study of the role of Visceral Adiposity in the pathogenesis of the polycystic ovary syndrome
  305. … effects of calcitriol on hypertension, glucose intolerance, impairment of endothelium-dependent vascular relaxation, and Visceral Adiposity in fructose-fed …
  306. The association of Visceral Adiposity with cardiovascular events in patients with peripheral artery disease
  307. Visceral Adiposity would be expected to predict incident diabetes better in women than men
  308. Visceral Adiposity Index and pattern of dyslipidaemia at different stages of glucose intolerance—A study from India
  309. Reduction in Visceral Adiposity is highly related to improvement in vascular endothelial dysfunction among obese women: an assessment of endothelial …
  310. Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and Visceral Adiposity
  311. Pregnancy in obese mice protects selectively against Visceral Adiposity and is associated with increased adipocyte estrogen signalling
  312. Racial differences between African-American and white women in insulin resistance and Visceral Adiposity are associated with differences in apoCIII …
  313. A Visceral Adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome
  314. Whole-body vibration partially reverses aging-induced increases in Visceral Adiposity and hepatic lipid storage in mice
  315. Low‐calorie diet induced weight loss may alter regulatory hormones and contribute to rebound Visceral Adiposity in obese persons with a family history of type‐2 …
  316. Multidisciplinary treatment reduces Visceral Adiposity tissue, leptin, ghrelin and the prevalence of non-alcoholic fat liver disease (NAFLD) in obese adolescents
  317. Subcutaneous adipose tissue insulin resistance is associated with Visceral Adiposity in postmenopausal women
  318. Can increased Visceral Adiposity without body weight changes accelerate carotid atherosclerosis in South Korean participants with type 2 diabetes?
  319. Visceral Adiposity in Saudi females and its relationship to diet and serum adipocytokine levels
  320. … PPARγ agonist, induces the expression of thermogenesis-related genes in brown fat and Visceral white fat and decreases Visceral Adiposity in obese and …
  321. Possibility radiological methods in diagnostics of Visceral Adiposity
  322. Glucose tolerance is affected by Visceral Adiposity and sex, but not birth weight, in Yucatan miniature pigs
  323. Effects of Visceral fat accumulation awareness on a web-based weight-loss program: Japanese study of Visceral Adiposity and lifestyle information—Utilization …
  324. Renal manifestations and Visceral Adiposity in apparently healthy Korean women
  325. Visceral Adiposity and its association with serum lipids in female obese teenagers
  326. Is Visceral Adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?
  327. Abdominal Visceral Adiposity influences CD4+ T cell cytokine production in pregnancy
  328. Changes in adiponectin and inflammatory genes in response to hormonal imbalances in female mice and exacerbation of depot selective Visceral Adiposity by high-fat …
  329. Influence of the body mass and Visceral Adiposity on glucose metabolism in obese women with Pro12Pro genotype in PPARgamma2 gene
  330. Beyond central Adiposity: liver fat and Visceral fat area are associated with metabolic syndrome in morbidly obese patients
  331. Visceral, subcutaneous abdominal Adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose …
  332. Utilizing quantitative measures of Visceral Adiposity in evaluating trauma patient outcomes
  333. Poor sleep quality potentiates stress-induced cytokine reactivity in postmenopausal women with high Visceral abdominal Adiposity
  334. Hepatocyte growth factor and interferon‐γ inducible protein‐10 are related to Visceral Adiposity
  335. Recombinant human growth hormone therapy in HIV-associated wasting and Visceral Adiposity
  336. Visceral Adiposity after tibolone use
  337. Maternal tobacco smoke increased Visceral Adiposity and serum corticosterone levels in adult male rat offspring
  338. The current version of the Visceral Adiposity index is not suitable for application in pediatric populations: comments on the article by Al-Daghri et al.
  339. A short-duration restrictive diet reduces Visceral Adiposity in the morbidly obese surgical patient
  340. Sex differences in the associations of Visceral Adiposity, homeostatic model assessment of insulin resistance, and body mass index with lipoprotein subclass analysis …
  341. Circulating irisin levels reflect Visceral Adiposity in non-diabetic patients undergoing hemodialysis
  342. Comment on: Padmavathi et al.(2010) Chronic Maternal Dietary Chromium Restriction Modulates Visceral Adiposity: Probable Underlying Mechanisms. Diabetes; 59 …
  343. … region of rat chromosome 8 in SHR-derived polydactylous congenic substrain affects muscle-specific insulin resistance, dyslipidaemia and Visceral Adiposity
  344. Influence of Visceral Adiposity on cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus
  345. … synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse Visceral Adiposity
  346. Central Nervous System Lipocalin‐Type Prostaglandin D2‐Synthase is Correlated with Orexigenic Neuropeptides, Visceral Adiposity and Markers of the …
  347. Cardiac Visceral Adiposity and right ventricle apex remodelling-Locus minoris resistentiae
  348. Influence of Visceral Adiposity on ghrelin secretion and expression in rats during fasting
  349. Novel relationships of age, Visceral Adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and …
  350. Application of Visceral Adiposity Index and Anthropometry to Identify Preclinical Atherosclerosis in Menopausal Status Women.
  351. Insulin sensitivity and secretion in youth onset type 2 diabetes with and without Visceral Adiposity
  352. Hypovitaminosis D is associated with Visceral Adiposity, high levels of low-density lipoprotein and triglycerides in alternating shift workers
  353. Association of Visceral and subcutaneous Adiposity with kidney function
  354. Visceral Adiposity and apolipoprotein C-III in apolipoprotein B-containing lipoproteins are independent predictors in determining atherogenic lipid profiles
  355. Noble rats display decreased weight gain and Visceral Adiposity via lifelong exposure to an isoflavone-rich diet
  356. Interventions for Visceral Adiposity associated with human immunodeficiency virus: application of a method for assessing efficacy
  357. Prevention of diabetes by fenofibrate in OLETF rats: hepatic mechanism for reducing Visceral Adiposity
  358. Body mass index, waist circumference, Visceral Adiposity, and cardiometabolic risk profile
  359. Computerized tomography measurement of Visceral Adiposity predicts plasma adiponectin levels and metastatic disease in patients with clear cell renal cell …
  360. Usefulness of the Visceral Adiposity index in different populations
  361. Visceral/epicardial Adiposity in nonobese and apparently healthy young adults: association with the cardiometabolic profile
  362. Relationship of Visceral and subcutaneous Adiposity with renal function in people with type 2 diabetes mellitus
  363. Association of Visceral Adiposity with urinary albumin excretion in type 2 diabetics
  364. The associations between various ectopic Visceral Adiposity and body surface electrocardiographic alterations: potential differences between local and …
  365. Adipose tissue gene expression profiling reveals distinct molecular pathways that define Visceral Adiposity in o…
  366. Visceral Adiposity and inflammation
  367. Computed tomography for assessment of Visceral Adiposity
  368. Comparison of Visceral Adiposity Index with Other Indices of Adiposity in Patients with Acute Myocardial Infarction
  369. The frequency of fish-eating could negatively associate with Visceral Adiposity in those who eat moderately
  370. Relationship of Visceral Adiposity with plasma adiponectin concentration: effect of weight loss
  371. Physiologic effects of GHRH in patients with HIV lipodystrophy: a model of acquired Visceral Adiposity
  372. Relationship between Visceral Adiposity and plasma adiponectin concentration: Effect of weight loss
  373. Visceral Adiposity index (vai), as the best predictor of insulin resistance and metablis syndrome in the women with polycystic ovary syndrome
  374. Role of Micro RNA-205 in Promoting Visceral Adiposity of NZ10 Mice with Polygenic Susceptibility for Type 2 Diabetes
  375. Visceral and subcutaneous Adiposity measurements in adults: influence of measurement site
  376. Gender Difference in Inflammatory Markers: What is the Contribution of Visceral Adiposity?
  377. The relationship between lipid accumulation product, Visceral Adiposity index and high-sensitivity C-reactive protein in healthy adults
  378. Hepatic steatosis, Visceral Adiposity, insulin resistance, adiponectin, and inflammation
  379. Comparison of Visceral Adiposity and obesity parameters in Caucasian and Hispanic adults
  380. Visceral and subcutaneous Adiposity: are both potential therapeutic targets for tackling the metabolic syndrome?
  381. Prediction of total and Visceral fat contents using anthropometric measures of Adiposity in women
  382. Lack of ST2 enhances high-fat diet-induced Visceral Adiposity and inflammation in BALB/c mice
  383. Visceral Adiposity and The Relationship Between Vitamin D and Adiponectin
  384. … a weight loss support web system on Visceral fat loss in a workplace setting: insights from a JVALUE2 (Japanese study of Visceral Adiposity and lifestyle information; …
  385. Association of Serum Retinol Binding Protein 4 and Visceral Adiposity in Chinese Diabetes and Non-Diabetes Subjects.
  386. Accuracy parameters as indicators of anthropometric Adiposity Visceral scheduled for two-dimensional equation
  387. Pubertal metformin therapy to reduce total, Visceral, and hepatic Adiposity
  388. Response to Comment on: Padmavathi et al.(2010) Chronic Maternal Dietary Chromium Restriction Modulates Visceral Adiposity: Probable Underlying Mechanisms …
  389. Age-related differences in inflammatory markers: Contribution of Visceral Adiposity
  390. AB0579 The relationship between Visceral Adiposity index and disability function in a cohort of psoriatic arthritis patients
  391. Increased Visceral Adiposity index in patients with polycystic ovary syndrome; relationship between inflammation, insulin resistance and hyperandrogenity
  392. Predicting total, abdominal, Visceral and hepatic Adiposity with circulating biomarkers in Caucasian and Japanese American women
  393. Visceral and not subcutaneous abdominal Adiposity reduction drives the benefits of a 1‐year lifestyle modification program
  394. Association between Visceral Adiposity, BMI, and clinical outcomes in postmenopausal women with operable breast cancer.
  395. Association between Visceral and subcutaneous Adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma
  396. Measurements of Visceral Adiposity, type-2 diabetes and risk for cardiovascular disease among Brazilian men and women
  397. The Sodium Glucose Co-transporter 2 Inhibitor (SGLT2i) Empagliflozin reduces weight and markers of Visceral Adiposity (VA) in type 2 diabetes (T2D) in short-and …
  398. Dietary fructose-related Adiposity and glucocorticoid receptor function in Visceral adipose tissue of female rats
  399. Prospective evidence that HIV lipoatrophy and Visceral Adiposity are partially independent processes
  400. Relationship of Visceral Adiposity index with serum aminotransferase and nonalcoholic fatty liver disease in patients with sleep apnea
  401. Visceral Adiposity cut-off points to indicate risk factor to develop the nonalcoholic fatty liver disease in Brazilian and Italian obese adolescents
  402. Effects of weight loss on Visceral Adiposity and metabolic adaptations in diabetic versus non-diabetic women
  403. Association of Visceral Adiposity with hypertension, dyslipidemia, and type 2 diabetes: a cross-sectional study among Japanese men and women
  404. Markers of Visceral Adiposity for Dementia Risk Assessment. The Epicardial Adipose Tissue (EAT) Thickness.
  405. Visceral Adiposity is Associated with Increased Risk of Anastomotic Leakage Following Surgery for Colorectal Cancer.
  406. Greater consumption of polyunsaturated fatty acids are related to increased lean mass and decreased Visceral Adiposity in a multi-ethnic sample of children
  407. Secretagogue type, sex-steroid milieu, and abdominal Visceral Adiposity individually determine secretagogue-stimulated cortisol secretion
  408. Sex differences in the associations of Visceral Adiposity, HOMA-IR, and BMI with lipoprotein subclass analysis in obese adolescents
  409. 665 Impact of Abdominal Visceral Adiposity on Left Ventricular Hypertrophy and Systolic Dysfunction in Patients With Aortic Stenosis-Results From the PROGRESSA …
  410. Grape seed extract decreases Visceral Adiposity and impairs the pro-tumorigenic adipose tissue secretions affecting colorectal cancer growth and progression
  411. Insulin Resistance, Visceral Adiposity Index and TyG Index in Genotype-4 Chronic HCV Patients and Their Relation to Hepatic Histopathology
  412. Ethnic and sex differences in body fat and Visceral and subcutaneous Adiposity in children and adolescents
  413. Association of Visceral Adiposity with increased intrarenal artery resistive index in HIV-1-infected patients receiving highly active antiretroviral therapy
  414. Anthropometric markers of Adiposity and Visceral Adiposity index (VAI) in patients with OSA
  415. Automated separation of Visceral and subcutaneous Adiposity in in vivo microcomputed tomographies of mice
  416. PP. 16.04: Visceral Adiposity INDEX AND CARDIOVASCULAR RISK IN THE ELDERLY
  417. Is BMI Good Enough to Measure Visceral Adiposity?
  418. What arises from the decrease of Visceral Adiposity in Japanese diabetic patients with Visceral fat accumulation?
  419. Psychosocial predictors of Visceral Adiposity
  420. Is Visceral Adiposity predictor of aortic diseases?
  421. Gender differences in the association of Visceral and subcutaneous Adiposity with adiponectin in African Americans: the Jackson Heart Study
  422. Association between NT-proBNP and Visceral Adiposity
  423. A Thyroid Hormone Receptor Gene Mutation(P 398 H) Is Associated with Visceral Adiposity and Impaired Catecholamine-stimulated Lipolysis in Mice
  424. Gator Circle: A new noninvasive method for evaluating Visceral Adiposity
  425. S-281: Increased risk for subclinical atherosclerosis in subjects with high Visceral Adiposity index
  426. Genetic determinants of Visceral Adiposity in Type 2 Diabetes Mellitus
  427. Assessment of Visceral Adiposity in rats submitted to high fat diet
  428. Sleep apnoea and Visceral Adiposity in middle-aged male and female
  429. Visceral Adiposity and Controlling Body Weight through Diet and Exercise
  430. HIGH Visceral Adiposity INDEX (VAI) SCORE BEFORE AND AFTER TREATMENT IN YOUNGH HIV-POSITIVE PATIENTS
  431. Visceral Adiposity associated with increased risk of death from ovarian cancer
  432. Does Visceral Adiposity Influence the Standard of Care Response for Hepatitis C Patients?
  433. Modeling Body Composition with Special Attention to Visceral Adiposity
  434. The use of Visceral Adiposity Variables in the evaluation of Obstructive Sleep Apnea: evidence from a large cross-sectional study
  435. IS Visceral Adiposity INDEX (VAI) RELATED TO PROSTATE CANCER DETECTED BY BIOPSY?
  436. Abstract MP028: Physical Activity Relates to Lower Visceral Adiposity in Children and Adolescents
  437. Aplicabilidad del Visceral Adiposity index (VAI) en la predicción de componentes del síndrome metabólico en adultos jóvenes
  438. Metabolic Control by Inflammation and Immunity: Inflammation mediates the association between Visceral Adiposity and obstructive sleep apnea in …
  439. Impact of Visceral Adiposity on blood pressure in normotensive people: a study among health staff
  440. Impact of Visceral Adiposity on outcomes from hepatocellular carcinoma following liver transplantation
  441. Can increased Visceral Adiposity without body weight changes accelerate carotid
  442. The association between BMI change and subcutaneous and Visceral Adiposity in adulthood: the Kangwha study
  443. Susceptibility variants for waist size in relation to abdominal, Visceral, and hepatic Adiposity in postmenopausal women
  444. Detection of Visceral Adiposity by ultrasonography and its relation to insulin resistance in HCV patients
  445. Perinatal iron deficiency results in increased Visceral Adiposity in male Wistar rats
  446. Visceral Adiposity and its association with serum lipids in female obese teenagers Adiposidad Visceral y su asociación con lípidos séricos e insulinemia en …
  447. THERE IS DISCORDANCE BETWEEN ARTERIAL STIFFNESS AND PERIPHERAL WAVE REFLECTIONS IN HYPERTENSIVES WITH Visceral Adiposity: PP …
  448. Evaluation of metabolic parameters in patients with craniopharyngiomas using Visceral Adiposity index
  449. Physical Activity Intensity and Visceral Adiposity in Youth: A Randomized Controlled Trial
  450. Visceral Adiposity: DISCORDANCE BETWEEN ARTERIAL STIFFNESS AND PERIPHERAL WAVE REFLECTIONS: PP. 34.361
  451. GW25-e1085 Predictive value of “Visceral Adiposity Index” for Type 2 Diabetes mellitus: A 15-year prospective cohort study
  452. Influence of Visceral Adiposity on cardiovascular autonomic function in type 2 diabetes
  453. Applicability of Visceral Adiposity Index in Predicting Metabolic Syndrome in Adults With Obstructive Sleep Apnea
  454. Effects of diet macronutrient composition on Visceral Adiposity during weight maintenance
  455. Exercise for reducing Visceral Adiposity: Aerobic or resistance training?
  456. Detection of Visceral Adiposity by Ultrasonography and its relation to insulin resistance in HCV patients
  457. Visceral Adiposity Index (VAI) as a simple indicator of “adipose tissue dysfunction” in patients with type 2 diabetes.
  458. Retention of sedentary obese Visceral white adipose tissue phenotype with intermittent physical activity despite reduced Adiposity
  459. Erratum for Nazare et al.“Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related
  460. Decreased Visceral Adiposity Accounts for Leptin’s Effect on Hepatic but not Peripheral Insulin Action
  461. Risk of NASH and severe fibrosis in patients with NAFLD and low Visceral Adiposity
  462. Visceral Adiposity & Insulin Impairment & Dementia/Alzheimer’s
  463. Visceral Adiposity, Liver Fat, and Atherogenic Dyslipidemia
  464. Adiposity and bone: the influence of subcutaneous versus Visceral fat and insulin resistance
  465. Visceral Adiposity and Leptin Are Independently Associated with CRP in Korean Type 2 Diabetic Patients.
  466. Metabolite Profiles Associated With Variation in Visceral Adiposity: The Multi-Ethnic Study of Atherosclerosis
  467. Visceral Adiposity Index and Serum 25-OH Vitamin D: Insights from the NHANES-III
  468. Abdominal Visceral Adiposity measured by ultrasonography and risk of metabolic syndrome and its components: identification of predictive cut-off of risk
  469. [PP. 27.12] Visceral Adiposity INDEX IS ASSOCIATED WITH NOCTURNAL HYPERTENSION BUT NOT NON-DIPPING PATTERN IN UNTREATED …
  470. Excess Visceral Adiposity is Related to Left Ventricular Hypertrophy and Dysfunction in Patients with Aortic Stenosis-Results from the PROGRESSA Study
  471. Visceral Adiposity is Associated with Persistently High and Less Variable Blood Pressure: Results From the Dallas Heart Study
  472. Testosterone and dehydroepiandrosterone deficiency, general Adiposity and Visceral obesity during normal male aging
  473. When Essential Hypertension is Combined With Visceral Adiposity There is Discordance Between Arterial Stiffness and Peripheral Wave Reflections
  474. Abstract P382: Visceral Adiposity is a Stronger Correlate of Plasma C-Reactive Protein Levels than Liver Fat in the INSPIRE ME IAA Study.
  475. Whole-and refined-grain intakes are differentially associated with abdominal Visceral and subcutaneous Adiposity in healthy adults: the Framingham Heart Study
  476. Abstract P222: Sex Differences in the Association of Visceral Adiposity with Lipoprotein Subclass Analysis in Obese Adolescents
  477. Cardiac and hepatic phenotype of diabetes in the presence and the absence of obesity-mechanistic role of ectopic/Visceral Adiposity
  478. Hypogonadism, insulin resistance and Visceral Adiposity in myotonic dystrophy
  479. Visceral Adiposity index as a marker of hepatic steatosis in overweight and obese premenopausal women
  480. Visceral Adiposity index-new anthropometric marker in women with polycystic ovary syndrome: preliminary reports
  481. … Lifestyle Intervention in Men with Features of the Metabolic Syndrome is Related to Improvements in Lipid Profile Independent of the Reduction in Visceral Adiposity
  482. Preeclampsia and Preterm Birth Associated With Visceral Adiposity in Early Pregnancy
  483. Impact of Visceral Adiposity on trabecular bone score in obese postmenopausal women: A cohort study
  484. BMI but not Visceral Adiposity index is related to vitamin D levels in overweight HIV-patients
  485. Lower dietary polyunsaturated to saturated fat ratio is associated with increased Visceral Adiposity
  486. Investigating the impact of subcutaneous and Visceral Adiposity on metabolism using an adipose tissue transplantation model
  487. Normalization of Visceral Adiposity is a Better Therapeutic Target Than Normalisation of Body Weight: Evidence From the Synergie Trial
  488. Visceral Adiposity index and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism
  489. Is Visceral Adiposity a Significant Correlate of Subcutaneous Adipose Cell Lipolysis in Men?
  490. EFFECTS OF CABERGOLINE TREATMENT ON METABOLIC SYNDROME AND Visceral Adiposity INDEX IN PATIENTS WITH HYPERPROLACTINEMIA.
  491. Abstract P263: Racial Differences in the Association Between Physical Activity Levels During Early Adulthood and Visceral Adiposity at Middle Age: The CARDIA …
  492. Ten Months of Exercise Improves General and Visceral Adiposity, Bone, and Fitness in Black Girls
  493. The nuclear receptor cochaperone FKBP51 is required for diet‐induced Visceral Adiposity
  494. B28 NOVEL APPROACHES TO PATIENT ASSESSMENT AND OUTCOMES OF PULMONARY REHABILITATION: Visceral Adiposity In Patients With COPD …
  495. Neck circumference is a powerful predictor of Visceral Adiposity and insulin resistance in morbid (WHO grade III) obesity
  496. Children with brain tumors have enhanced Visceral Adiposity compared to non-cancer controls: A preliminary analysis from the Canadian Study of Determinants …
  497. Evidence that Changes in Both Global Diet Quality and in Physical Activity Level Synergistically Reduce Visceral Adiposity in Men With the Metabolic Syndrome
  498. Visceral Adiposity index and metabolic profile in adult patients with congenital adrenal hyperplasia: hydrocortisone versus prednisone treatment.
  499. Viscous dietary fibers reduce Visceral Adiposity, lower oxidative stress and improve glucose control in ZDF rats
  500. Abstract P324: Abdominal Visceral Adiposity and Liver Fat in Relation to Sex-Related Differences in Cardiometabolic Risk Profile: The INSPIRE ME IAA Study
  501. LACK OF ST2 ENHANCES HIGH FAT DIET INDUCED Visceral Adiposity AND INFLAMMATION IN BALB/c MICE
  502. Greater fructose consumption is associated with cardiometabolic risk markers and Visceral Adiposity in adolescents.
  503. APPENDIX A. Diet quality is associated with lower total and Visceral Adiposity in Hispanic and non-Hispanic adolescent girls
  504. Intestinal Apolipoprotein A-IV Expression Conserves Visceral Adiposity in Mice Subjected to Cyclical Feeding and Fasting
  505. Thigh volume ratios assessed via stereovision body imaging as a predictor of Visceral Adiposity measured by magnetic resonance imaging
  506. Improvement in Hepatic Steatosis, Visceral Adiposity, and Appetite by High Dietary Protein Supplementation: 2155
  507. PP. 20.29: DISCORDANCE BETWEEN ARTERIAL STIFFNESS AND PERIPHERAL WAVE REFLECTIONS IN HYPERTENSIVES WITH Visceral Adiposity
  508. Abstract P332: Impact of Empagliflozin on Anthropometry and Markers of Visceral Adiposity in Patients With Type 2 Diabetes: Effects by Age, Sex, And Degree of …
  509. 156 INCREASED Visceral Adiposity IS ASSOCIATED WITH DECREASED GLOMERULAR FILTRATION RATE BY A MECHANISM INDEPENDENT OF …
  510. Skeletal muscle triglycerides and central Visceral Adiposity predict insulin sensitivity in lean, young, healthy subjects from two ethnic groups
  511. Dietary determinants of hepatic steatosis and Visceral Adiposity in overweight and obese youth at risk of type 2 diabetes1–3
  512. Fenofibrate Inhibits Visceral Adiposity by Inhibiting UCPs in C57BL/6J Mice Fed on a High Fat Diet
  513. Increased abdominal Visceral Adiposity is associated with unsuspected pulmonary embolism in hospitalised patients with malignant digestive tract tumours
  514. BMI, fat mass, abdominal Adiposity and Visceral fat: where is the ‘beef’?
  515. < The> possible role of Visceral Adiposity in development of pro-atherogenic lipid profile in normal overweight young Egyptian female adults [a possible involvement of …
  516. Risk of early atherosclerosis by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease and low Visceral Adiposity
  517. … for early gastric cancer is associated with decreased cardiovascular mortality in accordance with amelioration of metabolic abnormalities, Visceral Adiposity and …
  518. Correlation of computerized tomography measurement of Visceral Adiposity with plasma adiponectin levels and presence of metastatic disease in patients with clear …
  519. The Findrisc score, Visceral Adiposity, insulin sensitivity and secretion estimates are independent predictors of type 2 diabetes in obese and overweight subjectsA
  520. Anthropometric correlates of total body fat, Visceral Adiposity and cardio-metabolic health risk: a community cohort study of urban, adult Sri Lankans
  521. The processing of wheat bran to release bound phenolic compounds improves insulin resistance and reduces Visceral Adiposity and liver cholesterol in ZDF rat
  522. Routine clinical measures of Adiposity as predictors of Visceral fat in adolescence: a population-based magnetic resonance imaging study
  523. Alternate‐day fasting and daily calorie restriction similarly affect Visceral Adiposity and circulating inflammatory cytokine concentrations
  524. Liver fat, Visceral Adiposity, and sleep disturbances contribute to the development of insulin resistance and glucose intolerance in nondiabetic dialysis patients
  525. … TESTING AND SYMPTOM EVALUATION IN CHRONIC RESPIRATORY DISEASE: Evaluation Of Cardiometabolic Risk Profile And Visceral Adiposity In Patients With …
  526. Abdominal Visceral Adiposity, Fatty Liver and Renin-Angiotensin-Aldosterone System: The Jackson Heart Study
  527. 190: Computerized Tomography Measurement of Visceral Adiposity Predicts Plasma Adiponectin Levels and Presence of Metastatic Disease in Patients with Clear …
  528. P. 084 Visceral Adiposity AS THE MAIN DETERMINANT OF CAROTID STIFFNESS IN A HEALTHY POPULATION WITH A WIDE BMI AND AGE RANGE …
  529. POD-6.11: Computerized Tomography Measurement of Visceral Adiposity Predicts Plasma Adiponectin Levels and Presence of Metastatic Disease in Patients with …
  530. Visceral fat but not general Adiposity is a predictor of sub-clinical atherosclerosis in HIV-infected patients with lipodystrophy.
  531. Are Changes In 25 (OH) Vitamin D Levels And Changes In Insulin Secretion Mediated By Changes In Visceral Adiposity? Results From A Lifestyle Intervention …
  532. Multiparity Is Associated with Type 2 Diabetes Independent of Adiponectin and Visceral Adiposity.
  533. Insulin Resistance (IR) and β-Cell Dysfunction, but not Visceral Adiposity, Predict New Onset Diabetes in Hispanics (HA) and African Americans (AA): The IRAS Family …
  534. GQ‐16, a novel partial PPARγ ligand, decreases Visceral Adiposity and induces the expression of thermogenesis‐related genes in mice with obesity and insulin …
  535. Visceral and subcutaneous Adiposity and adiponectin in middle‐aged Japanese men: the ERA JUMP study
  536. Differential effect of marrow Adiposity and Visceral and subcutaneous fat on cardiovascular risk in young, healthy adults
  537. Abdominal Adiposity with respect to the proportion of intra-abdominal Visceral fat to extra-abdominal fat (VS ratio) in Japanese childhood obesity
  538. A pilot investigation of Visceral fat Adiposity and gene expression profile in peripheral blood cells
  539. PP. 05.24: THE SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR EMPAGLIFLOZIN REDUCES WEIGHT AND MARKERS OF Visceral Adiposity IN TYPE 2 …
  540. Effects of short (12 months) and long (60 months) term treatment with cabergoline on metabolic syndrome and Visceral Adiposity index in patients with …
  541. Chitinase 3 Like 1 (CHI3L1) Is A Critical Regulator Of Visceral Adiposity And The PPAR Pathway
  542. Visceral and subcutaneous Adiposity and brachial artery vasodilator function
  543. Ultrasound measurements of Visceral and subcutaneous abdominal thickness to predict abdominal Adiposity among older men and women
  544. Study on correlation of abdominal height with Visceral fat area and the cutoff points to predict abdominal Adiposity
  545. Analysis of Visceral and subcutaneous Adiposity via micro-computer tomography
  546. Anthropometric Measures of Adiposity as Predictors of Visceral and Subcutaneous Fat in Adolescence: The Saguenay Youth Study
  547. Short-term effects of liraglutide on Visceral fat Adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes
  548. Treatment of obese diabetic mice with a heme oxygenase inducer reduces Visceral and subcutaneous Adiposity, increases adiponectin levels, and improves insulin …
  549. Effects of microvascular complications on structural changes in Visceral and subcutaneous Adiposity among type 2 diabetes patients
  550. FTIR imaging of structural changes in Visceral and subcutaneous Adiposity and brown to white adipocyte transdifferentiation
  551. Insulin therapy induced Adiposity evaluated by computed tomography is not Visceral
  552. Switch to Raltegravir from PI or NNRTI Does Not Reduce Visceral Fat in HIV-Infected Women with Central Adiposity
  553. … inhibitor or nonnucleoside reverse-transcriptase inhibitor does not reduce Visceral fat in human immunodeficiency virus-infected women with central Adiposity
  554. In adult twins, Visceral fat accumulation depends more on exceeding sex-specific Adiposity thresholds than on genetics
  555. Insulin therapy induced Adiposity evaluted by computed tomography is not Visceral
  556. A Pilot Investigation of Visceral Fat Adiposity and Gene Expression Profile in Peripheral Blood Cells
  557. Increasing Adiposity in normal ovulatory women affects adipocytokine expression in subcutaneous and Visceral abdominal fat
  558. Visceral and Abdominal Adiposity Using Thoracic-Abdominal Profile Image Acquisition database
  559. Subcutaneous and Visceral adipose tissue FTO gene expression and Adiposity, insulin action, glucose metabolism, and inflammatory adipokines in type 2 diabetes …
  560. Carotid IMT values are related to insulin resistance and Visceral disposition of Adiposity in obese patients
  561. Diet-induced alterations in energy homeostasis and central Adiposity: liver and Visceral adipose tissue
  562. Liver Enzymes Correlate with Visceral but not Subcutaneous Adiposity: the IRAS Family Study.
  563. Corrigendum: Visceral and Subcutaneous Adiposity and Adiponectin in Middle-aged Japanese Men: The ERA JUMP Study
  564. Lipolysis, lipogenesis, and Adiposity are reduced while fatty acid oxidation is increased in Visceral and subcutaneous adipocytes of endurance-trained rats
  565. … of 11β-hydroxysteroid dehydrogenase type 1 in Visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with Adiposity
  566. Genome-wide blood leukocyte DNA methylation in relation to Visceral, subcutaneous, and hepatic Adiposity in postmenopausal women.
  567. Suppression of isoproterenol-induced lipolysis by insulin in rat Visceral adipose tissue explants is increased with aging: Consequences on Adiposity
  568. Baseline and Change in Visceral and Subcutaneous Adiposity Predict Future HDL Cholesterol, Triglycerides, and non HDL Cholesterol Levels in Japanese …
  569. Treatment of Obese Diabetic Mice with an Heme Oxygenase Inducer Reduces Visceral and Abdominal Adiposity, Increases Adiponectin Levels and Improves Insulin …
  570. 475: ABDOMINAL Visceral AND SUBCUTANEOUS Adiposity ARE ASSOCIATED WITH ACUTE KIDNEY INJURY IN CRITICALLY ILL TRAUMA PATIENTS
  571. Contribution of genetics to Visceral Adiposity and its relation to cardiovascular and metabolic disease
  572. Computed tomography highlights increased Visceral Adiposity associated with critical illness in COVID-19
  573. Visceral Adiposity elevates the risk of critical condition in COVID‐19: A systematic review and meta‐analysis
  574. Visceral Adiposity index and 10-year cardiovascular disease incidence: the ATTICA study
  575. The role of Visceral Adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany
  576. The fat of the matter: obesity and Visceral Adiposity in treated HIV infection
  577. Visceral Adiposity and sarcopenic Visceral obesity are associated with poor prognosis after resection of pancreatic cancer
  578. Visceral Adiposity predicts post‐operative Crohn’s disease recurrence
  579. Visceral Adiposity and cancer survival: a review of imaging studies
  580. Visceral Adiposity, subcutaneous Adiposity, and severe coronavirus Disease-2019 (COVID-19): systematic review and meta-analysis
  581. Derivation and validation of a new Visceral Adiposity index for predicting Visceral obesity and cardiometabolic risk in a Korean population
  582. Exercise reduces liver lipids and Visceral Adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial
  583. Visceral Adiposity and high intramuscular fat deposition independently predict critical illness in patients with SARS‐CoV‐2
  584. Visceral Adiposity, genetic susceptibility, and risk of complications among individuals with Crohn’s disease
  585. Association between blood mercury level and Visceral Adiposity in adults
  586. Heart rate variability reduction is related to a high amount of Visceral Adiposity in healthy young women
  587. New indexes of body fat distribution, Visceral Adiposity index, body Adiposity index, waist-to-height ratio, and metabolic disturbances in the obese
  588. Visceral Adiposity predicts severity of acute pancreatitis
  589. Low skeletal muscle radiation attenuation and Visceral Adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer
  590. Associations between abdominal obesity indices and diabetic complications: Chinese Visceral Adiposity index and neck circumference
  591. Visceral Adiposity index as a predictor of NAFLD: A prospective study with 4‐year follow‐up
  592. Visceral Adiposity index is associated with lung function impairment: a population-based study
  593. Visceral Adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives
  594. Menopausal hormone therapy is associated with reduced total and Visceral Adiposity: the OsteoLaus Cohort
  595. Changes in Visceral Adiposity, subcutaneous Adiposity, and sex hormones in the diabetes prevention program
  596. Visceral Adiposity index as a predictor for type 2 diabetes mellitus in Asian population: a systematic review
  597. The use of Visceral Adiposity variables in the prediction of obstructive sleep apnea: evidence from a large cross-sectional study
  598. Obesity, Visceral Adiposity and carotid atherosclerosis
  599. Fructose-induced inflammation and increased cortisol: A new mechanism for how sugar induces Visceral Adiposity
  600. Visceral Adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype
  601. Impact of Visceral Adiposity on severity of acute pancreatitis: a propensity score-matched analysis
  602. Chinese Visceral Adiposity index: A reliable indicator of Visceral fat function associated with risk of type 2 diabetes
  603. Low plasma adiponectin concentrations predict increases in Visceral Adiposity and insulin resistance
  604. Validity of Visceral Adiposity estimates from DXA against MRI in Kuwaiti men and women
  605. Visceral Adiposity index as an independent marker of subclinical atherosclerosis in individuals prone to diabetes mellitus
  606. Visceral Adiposity links cerebrovascular dysfunction to cognitive impairment in middle-aged mice
  607. A Novel Visceral Adiposity Index for Prediction of Type 2 Diabetes and Pre-diabetes in Chinese adults: A 5-year prospective study
  608. Visceral Adiposity index as a useful tool for the assessment of cardiometabolic disease risk in women aged 65 to 74
  609. Association between coronary atherosclerosis and Visceral Adiposity index
  610. Adiponectin expression in Visceral Adiposity is an important determinant of insulin resistance in morbid obesity
  611. Fibroblast growth factor receptor is a mechanistic link between Visceral Adiposity and cancer
  612. Effect of exercise and pharmacological interventions on Visceral Adiposity: a systematic review and meta-analysis of long-term randomized controlled trials
  613. Comparisons of Visceral Adiposity index, body shape index, body mass index and waist circumference and their associations with diabetes mellitus in adults
  614. Effects of Visceral Adiposity on glycerol pathways in gluconeogenesis
  615. Visceral Adiposity and metabolic syndrome after very high–fat and low-fat isocaloric diets: A randomized controlled trial
  616. Relation of plasma ceramides to Visceral Adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study
  617. Relationship of oxidative stress to Visceral Adiposity in youth and role played by vitamin D
  618. Preoperative Visceral Adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma
  619. Proposal for new selection criteria considering pre‐transplant muscularity and Visceral Adiposity in living donor liver transplantation
  620. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of Visceral Adiposity and incident type 2 diabetes
  621. Visceral Adiposity index as a predictor of chronic kidney disease in a relatively healthy population in Taiwan
  622. Visceral Adiposity and glucoregulatory peptides are associated with susceptibility to type 2 diabetes: the TOFI_Asia study
  623. Amygdalar metabolic activity independently associates with progression of Visceral Adiposity
  624. Visceral Adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes
  625. Chronic inflammation in psoriasis promotes Visceral Adiposity associated with noncalcified coronary burden over time
  626. The role of the growth hormone/insulin-like growth factor system in Visceral Adiposity
  627. Visceral Adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and …
  628. Effect of Ramadan diurnal fasting on Visceral Adiposity and serum adipokines in overweight and obese individuals
  629. Impact of skeletal muscle mass, muscle quality, and Visceral Adiposity on outcomes following resection of intrahepatic cholangiocarcinoma
  630. Association of changes in commute mode with body mass index and Visceral Adiposity: a longitudinal study
  631. Increased Visceral Adiposity index associated with sexual dysfunction in men
  632. Visceral Adiposity and renal function: an observational study from SPECT-China
  633. Impact of abdominal Visceral Adiposity on adult asthma symptoms
  634. The role of Visceral Adiposity index levels in predicting the presence of metabolic syndrome and insulin resistance in overweight and obese patients
  635. Diet quality in midadulthood predicts Visceral Adiposity and liver fatness in older ages: the Multiethnic Cohort Study
  636. The role of inflammation in the association between overall and Visceral Adiposity and subclinical atherosclerosis
  637. Estradiol signaling mediates gender difference in Visceral Adiposity via autophagy
  638. Influence of Visceral Adiposity accumulation on adverse left and right ventricular mechanics in the community
  639. Metabolomic signatures for Visceral Adiposity and dysglycaemia in Asian Chinese and Caucasian European adults: the cross-sectional TOFI_Asia study
  640. Visceral Adiposity increases the risk of breast cancer: a case-control study
  641. Preeclampsia and preterm birth associated with Visceral Adiposity in early pregnancy
  642. Visceral Adiposity index and lipid accumulation product as a predictor of type 2 diabetes mellitus: the Bogor cohort study of non-communicable diseases risk factors
  643. Visceral Adiposity Index in Breast Cancer Survivors: A Case-Control Study
  644. Discriminatory ability of Visceral Adiposity index (VAI) in diagnosis of metabolic syndrome: a population based study
  645. Neutrophil‐to‐lymphocyte ratio and its relation with pro‐inflammatory mediators, Visceral Adiposity and carotid intima‐media thickness in population with obesity
  646. Visceral Adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant
  647. Carotid stiffness, extra-media thickness and Visceral Adiposity in young adults
  648. Anthropometric cutoffs and associations with Visceral Adiposity and metabolic biomarkers after spinal cord injury
  649. Visceral Adiposity index was a useful predictor of prediabetes
  650. Effects of intermittent energy restriction combined with a Mediterranean diet on reducing Visceral Adiposity: a randomized active comparator pilot study
  651. Association between the Visceral Adiposity index and homeostatic model assessment of insulin resistance in participants with normal waist circumference
  652. Body Adiposity index, but not Visceral Adiposity index, correlates with inflammatory markers in sarcopenic obese elderly women
  653. Association Between Liver Fat and Bone Density is Confounded by General and Visceral Adiposity in a Community‐Based Cohort
  654. Can High Visceral Adiposity Index Be a Risk Factor for Sexual Dysfunction in Sexually Active Men?
  655. Anthropometric indicators of Visceral Adiposity as predictors of non-alcoholic fatty liver disease: a review
  656. Visceral Adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome
  657. Anthropometric prediction of Visceral Adiposity in persons with spinal cord injury
  658. Nonalcoholic fatty liver disease is associated with both subcutaneous and Visceral Adiposity: A cross-sectional study
  659. TG/HDL-C ratio and Visceral Adiposity index may be useful in assessment of insulin resistance in adults with type 1 diabetes in clinical practice
  660. Lower subcutaneous or Visceral Adiposity assessed by abdominal computed tomography could predict adverse outcome in patients with Crohn’s disease
  661. Independent association between the Visceral Adiposity index and microalbuminuria in patients with newly diagnosed type 2 diabetes
  662. The Visceral Adiposity index is a predictor of incident nonalcoholic fatty liver disease: a population-based longitudinal study
  663. Association of Visceral Adiposity with pain but not structural osteoarthritis
  664. Maternal high-fat diet during suckling programs Visceral Adiposity and epigenetic regulation of adipose tissue stearoyl-CoA desaturase-1 in offspring
  665. Visceral Adiposity index is useful for evaluating obesity effect on erectile dysfunction
  666. The associations between neutrophil-to-lymphocyte ratio and the Chinese Visceral Adiposity Index, and carotid atherosclerosis and atherosclerotic cardiovascular …
  667. Association of Visceral Adiposity and its longitudinal increase with the risk of diabetes in Chinese adults: A prospective cohort study
  668. Visceral Adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes
  669. Serum chemerin levels are associated with Visceral Adiposity, independent of waist circumference, in newly diagnosed type 2 diabetic subjects
  670. Alteration of Glucidic Metabolism in Relation with Visceral Adiposity Index
  671. Estimated Visceral Adiposity is associated with risk of cardiometabolic conditions in a population based study
  672. Visceral Adiposity and Cancer: Role in Pathogenesis and Prognosis
  673. Association of Visceral Adiposity and systemic inflammation with sleep disordered breathing in normal weight, never obese adolescents
  674. Effect of resistance training on liver fat and Visceral Adiposity in adults with obesity: A randomized controlled trial
  675. Beneficial effects of Apple Cider Vinegar on weight management, Visceral Adiposity Index and lipid profile in overweight or obese subjects receiving restricted calorie …
  676. Are Visceral Adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?
  677. Matrix Gla protein regulates adipogenesis and is serum marker of Visceral Adiposity
  678. The use of Visceral Adiposity index to predict diabetes remission in low BMI Chinese patients after bariatric surgery
  679. Dietary intake of carotenoid-rich vegetables reduces Visceral Adiposity in obese Japanese men—a randomized, double-blind trial
  680. Visceral Adiposity index is associated with increased urinary albumin excretion: a population-based study
  681. COVID‐19 rise in Younger adults with Obesity: Visceral Adiposity can predict the Risk
  682. Epigallocatechin-3-Gallate Reduces Visceral Adiposity Partly through the Regulation of Beclin1-Dependent Autophagy in White Adipose Tissues
  683. Effects of metformin administration on endocrine-metabolic parameters, Visceral Adiposity and cardiovascular risk factors in children with obesity and risk …
  684. A role for FGF2 in Visceral Adiposity-associated mammary epithelial transformation
  685. Visceral Adiposity and insular networks: associations with food craving
  686. Visceral Adiposity index in female with type 2 diabetic mellitus and its association with the glycemic control
  687. Visceral Adiposity and liver fat as mediators of the association between cardiorespiratory fitness and plasma glucose-insulin homeostasis
  688. Effect of Gum Arabic (Acacia Senegal) supplementation on Visceral Adiposity index (VAI) and blood pressure in patients with type 2 diabetes mellitus as …
  689. Triglycerides and waist to height ratio are more accurate than Visceral Adiposity and body Adiposity index to predict impaired fasting glucose
  690. Total and Visceral Adiposity are associated with prevalent vertebral fracture in women but not men at age 62 years: the Newcastle Thousand Families Study
  691. Visceral Adiposity index is closely associated with urinary albumin‐creatinine ratio in the Chinese population with prediabetes
  692. Discriminatory ability of Visceral Adiposity index as an indicator for modeling cardio-metabolic risk factors in pediatric population: the CASPIAN-V study
  693. Lipid accumulation product (LAP) and Visceral Adiposity index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine …
  694. Visceral Adiposity indicators as predictors of metabolic syndrome in postmenopausal women
  695. Can Visceral Adiposity index serve as a simple tool for identifying individuals with insulin resistance in daily clinical practice?
  696. Predicting metabolic syndrome by Visceral Adiposity index, body roundness index and a body shape index in adults: a cross-sectional study from the Iranian …
  697. The significance of the effect of Visceral Adiposity on left ventricular diastolic function in the general population
  698. Visceral Adiposity index, lipid accumulation product and intracranial atherosclerotic stenosis in middle-aged and elderly Chinese
  699. Excess Visceral Adiposity is associated with diabetic retinopathy in a multiethnic Asian cohort with longstanding type 2 diabetes
  700. Cholic acid enhances Visceral Adiposity, atherosclerosis and nonalcoholic fatty liver disease in microminipigs
  701. Visceral Adiposity index (VAI) in children and adolescents with obesity: No association with daily energy intake but promising tool to identify metabolic syndrome (MetS …
  702. Associations between reliable changes in depression and changes in BMI, total body fatness and Visceral Adiposity during a 12-month weight loss trial
  703. Associations between physical activity and BMI, body fatness, and Visceral Adiposity in overweight or obese Latino and non-Latino adults
  704. Utility of the Visceral Adiposity index and hypertriglyceridemic waist phenotype for predicting incident hypertension
  705. Visceral Adiposity index outperforms common anthropometric indices in predicting 10‐year diabetes risk: Results from the ATTICA study
  706. Gastric mucosal devitalization is safe and effective in reducing body weight and Visceral Adiposity in a porcine model
  707. The association of plant-based dietary patterns with Visceral Adiposity, lipid accumulation product, and triglyceride-glucose index in Iranian adults
  708. Relationship of Visceral Adiposity index with new-onset proteinuria in hypertensive patients
  709. Visceral Adiposity and expression of clock genes in peripheral blood mononuclear cells: A pilot study
  710. Positively increased Visceral Adiposity index in hyperuricemia free of metabolic syndrome
  711. Hypertriglyceridemic waist: a simple marker of high‐risk atherosclerosis features associated with excess Visceral Adiposity/ectopic fat
  712. Non-obese Visceral Adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study
  713. Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Beyond …
  714. Visceral Adiposity index: Simple Tool for assessing cardiometabolic risk in women with polycystic ovary syndrome
  715. Visceral Adiposity index and chronic kidney disease in a non-diabetic population: a cross-sectional study
  716. Lipid accumulation product and Visceral Adiposity index are associated with dietary patterns in adult Americans
  717. Importance of Measured Body Fat, Visceral Adiposity Index, and Lipid Accumulation Product Index in Predicting Cardiometabolic Risk Factors
  718. Triglyceride paradox is related to lipoprotein size, Visceral Adiposity and Stearoyl-CoA desaturase activity in black versus white women
  719. Association of Visceral Adiposity and insulin resistance with colorectal adenoma and colorectal cancer
  720. Dynamics of body mass index and Visceral Adiposity index in patients with rheumatoid arthritis treated with tofacitinib
  721. Impact of Visceral Adiposity as well as sarcopenic factors on outcomes in patients undergoing liver resection for colorectal liver metastases
  722. Usefulness of a new anthropometric indicator: VAI (Visceral Adiposity Index) in the evaluation of metabolic and hormonal disorders in women with polycystic …
  723. Sarcopenia and Visceral Adiposity did not affect efficacy of immune-checkpoint inhibitor monotherapy for pretreated patients with advanced non-small cell lung …
  724. Insulin-like growth factor-II in adipocyte regulation: depot-specific actions suggest a potential role limiting excess Visceral Adiposity
  725. Insulin resistance associated with plasma xanthine oxidoreductase activity independent of Visceral Adiposity and adiponectin level: MedCity21 Health …
  726. The relationship between Visceral Adiposity index and epicardial adipose tissue in patients with type 2 diabetes mellitus
  727. Association of Visceral Adiposity surrogates with impaired fasting glucose in nonobese individuals
  728. Morus alba L. Diminishes Visceral Adiposity, insulin resistance, behavioral alterations via regulation of gene expression of leptin, resistin and adiponectin in rats fed a …
  729. Visceral Adiposity predicts subclinical white matter hyperintensities in middle-aged adults
  730. Visceral Adiposity index levels in patients with hypothyroidism
  731. The association between Visceral Adiposity with systemic inflammation, oxidative stress, and risk of post-surgical adhesion
  732. Visceral Adiposity and inflammatory bowel disease
  733. Lipid accumulation product and Visceral Adiposity index: two new indices to predict metabolic syndrome in chronic kidney disease
  734. The impact of lipid accumulation product (LAP) and Visceral Adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary …
  735. Treatment with cinnamaldehyde reduces the Visceral Adiposity and regulates lipid metabolism, autophagy and endoplasmic reticulum stress in the liver of a rat model …
  736. Lipid accumulation product, Visceral Adiposity index, and chinese Visceral Adiposity index as markers of cardiometabolic risk in adult growth hormone deficiency …
  737. Quantification of scan analysis errors in GE lunar DXA Visceral Adiposity in adults
  738. Visceral Adiposity is associated with pain, but not structural osteoarthritis
  739. Independent and additive effects of coenzyme Q10 and vitamin E on cardiometabolic outcomes and Visceral Adiposity in women with polycystic ovary syndrome
  740. Exercise versus pharmacological interventions for reducing Visceral Adiposity and improving health outcomes
  741. Interaction between Visceral Adiposity and ambient air pollution on LDL cholesterol level in Korean adults
  742. Chronic hypercortisolism causes more persistent Visceral Adiposity than HFD-induced obesity
  743. Association of obesity, Visceral Adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study
  744. Association of the triglyceride to high-density lipoprotein ratio and the Visceral Adiposity index with metabolic syndrome in diabetic susceptible population
  745. Visceral Adiposity index is a better predictor of type 2 diabetes than body mass index in Qatari population
  746. The association between serum ferritin concentration and Visceral Adiposity estimated by whole-body DXA scan in women with polycystic ovary syndrome
  747. The relationship between Visceral Adiposity and depressive symptoms in the general Korean population
  748. The Visceral Adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency
  749. Evaluation of the relationship between serum ferritin and insulin resistance and Visceral Adiposity index (VAI) in women with polycystic ovary syndrome
  750. Visceral Adiposity index is associated with silent brain infarct in a healthy population
  751. Fructo-oligosaccharides ameliorate steatohepatitis, Visceral Adiposity, and associated chronic inflammation via increased production of short-chain fatty acids …
  752. Visceral Adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives
  753. Smallanthus sonchifolius (yacon) flour improves Visceral Adiposity and metabolic parameters in high-fat-diet-fed rats
  754. Visceral Adiposity in Relation to Body Adiposity and Nutritional Status in Elderly Patients with Stable Coronary Artery Disease
  755. Visceral Adiposity and diet quality are differentially associated with cognitive abilities and early academic skills among preschool-age children
  756. Visceral Adiposity index as a practical tool in patients with biopsy-proven nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
  757. Impact of high Visceral Adiposity index associated with metabolic syndrome on erectile function in sexually active men: Results of a cross‐sectional study
  758. Sensitivity of various body indices and Visceral Adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone …
  759. Visceral Adiposity Index (VAI)–a potential marker of cardiometabolic risk
  760. Hepatic and skeletal muscle Adiposity are associated with diabetes independent of Visceral Adiposity in nonobese African-Caribbean men
  761. Visceral Adiposity index is associated with benign prostatic enlargement in non-diabetic patients: a cross-sectional study
  762. Thyroid stimulating hormone within the reference range is associated with Visceral Adiposity index and lipid accumulation product: a population-based study of SPECT …
  763. The Accuracy of Visceral Adiposity Index for the Screening of Metabolic Syndrome: A Systematic Review and Meta-Analysis
  764. Association of dietary patterns with Visceral Adiposity, lipid accumulation product, and triglyceride-glucose index in Iranian adults
  765. Nonlinear relationship between Visceral Adiposity index and lung function: a population-based study
  766. Role of Nampt and Visceral Adiposity in esophagogastric junction adenocarcinoma
  767. Association between Visceral Adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trial
  768. Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela
  769. Visceral Adiposity index and longitudinal risk of incident metabolic syndrome: Korean genome and epidemiology study (KoGES)
  770. Visceral Adiposity is an independent determinant of hypercoagulability as measured by thrombin generation in morbid obesity
  771. Neck circumference, Visceral Adiposity, and hypertension: does upper body Adiposity outperforms Visceral Adiposity in terms of hypertension predictions?
  772. Genetic and Environmental Factors Contributing to Visceral Adiposity in Asian Populations
  773. Gender difference in the association of chronic kidney disease with Visceral Adiposity index and lipid accumulation product index in Korean adults: Korean National …
  774. Change in Visceral Adiposity is an independent predictor of future arterial pulse pressure
  775. Systemic inflammation mediates the negative relationship between Visceral Adiposity and cognitive control
  776. Visceral Adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma
  777. LIPC variants as genetic determinants of Adiposity status, Visceral Adiposity indicators, and triglyceride-glucose (TyG) index-related parameters mediated by …
  778. Increasing changes in Visceral Adiposity is associated with higher risk for colorectal adenoma: Multilevel analysis in a prospective cohort
  779. Role of exercise on Visceral Adiposity after spinal cord injury: a cardiometabolic risk factor
  780. Relationship of total hemoglobin in subcutaneous adipose tissue with whole-body and Visceral Adiposity in humans
  781. Effect of genetic liability to Visceral Adiposity on stroke and its subtypes: A Mendelian randomization study
  782. Exenatide with metformin ameliorated Visceral Adiposity and insulin resistance
  783. Predictive performance of lipid accumulation product and Visceral Adiposity index for renal function decline in non-diabetic adults, an 8.6-year follow-up
  784. The association of the Visceral Adiposity index with insulin resistance and beta-cell function in Korean adults with and without type 2 diabetes mellitus
  785. Visceral Adiposity index associated with behavioral and inflammatory parameters in adults: a population based study
  786. Visceral Adiposity Index Is Inversely Associated with Renal Function in Normal-Weight Adults with Hypertension: The China H-Type Hypertension Registry Study
  787. The mediating role of Visceral Adiposity in the relationship among schooling, physical inactivity, and unhealthy metabolic phenotype
  788. Biomarker-based Visceral Adiposity score and incident type 2 diabetes in the multiethnic cohort
  789. Visceral Adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran
  790. Visceral Adiposity index is associated with premature ejaculation inversely: a cross-sectional study
  791. A disintegrin and metalloproteinase with thrombospondin motifs 18 deficiency leads to Visceral Adiposity and associated metabolic syndrome in mice
  792. Visceral Adiposity Index is a predictor of incident colorectal cancer: a population-based longitudinal study
  793. Association Between Chinese Visceral Adiposity Index and Incident Type 2 Diabetes Mellitus in Japanese Adults
  794. Comparing anthropometric indicators of Visceral and general Adiposity as determinants of overall and cardiovascular mortality
  795. Vitamin D supplementation decreases Visceral Adiposity and normalizes leptinemia and circulating TNF-α levels in western diet-fed obese rats
  796. Towards a simple marker of hepato‐Visceral Adiposity and insulin resistance: The Z‐score change from weight‐at‐birth to BMI‐in‐childhood
  797. Association between Visceral Adiposity Index, Binge Eating Behavior, and Grey Matter Density in Caudal Anterior Cingulate Cortex in Severe Obesity
  798. The Visceral Adiposity index is a predictor of incident chronic kidney disease: a population-based longitudinal study
  799. Association of Visceral Adiposity index with new-onset type 2 diabetes and impaired fasting glucose in hypertensive Chinese adults
  800. Clinical and biochemical markers of Visceral adipose tissue activity: Body mass index, Visceral Adiposity index, leptin, adiponectin, and matrix …
  801. Visceral Adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes
  802. CT-based assessment of Visceral Adiposity and outcomes for esophageal adenocarcinoma
  803. Visceral Adiposity index and cervical arterial atherosclerosis in northeast China: a population based cross‐sectional survey
  804. Dietary intervention, when not associated with exercise, upregulates irisin/FNDC5 while reducing Visceral Adiposity markers in obese rats
  805. The starch-rich diet causes lipidemia while the fat-rich diet induces Visceral Adiposity, meta-inflammation, and insulin resistance differentially in immune biased mouse …
  806. Visceral Adiposity, muscle composition, and exercise tolerance in heart failure with preserved ejection fraction
  807. Importance of general Adiposity, Visceral Adiposity and vital signs in predicting blood biomarkers using machine learning
  808. Reduction of Visceral Adiposity as a Predictor for Resolution of Nonalcoholic Fatty Liver in Potential Living Liver Donors
  809. The relation of CT quantified pancreatic fat index with Visceral Adiposity and hepatic steatosis
  810. Resistance training promotes reduction in Visceral Adiposity without improvements in Cardiomyocyte Contractility and Calcium handling in Obese Rats
  811. Association of the new Visceral Adiposity index with coronary artery calcification and arterial stiffness in Korean population
  812. Correlation between pre‐pregnancy body mass index and maternal Visceral Adiposity with fetal biometry during the second trimester
  813. So as we worry we weigh: visible burrow system stress and Visceral Adiposity
  814. Supplementation of suckling rats with cow’s milk induces hyperphagia and higher Visceral Adiposity in females at adulthood, but not in males
  815. Role of endothelium‐independent vasodilation in the relationship between Visceral Adiposity and reduced cognitive performance in older adults with type 2 diabetes
  816. Visceral Adiposity as a risk factor for lean non‐alcoholic fatty liver disease in potential living liver donors
  817. Apolipoprotein B Levels Predict Future Development of Hypertension Independent of Visceral Adiposity and Insulin Sensitivity
  818. Association of Visceral Adiposity index with insulin resistance in adults with diabetes mellitus
  819. The Visceral Adiposity index predicts the severity of hyperlipidaemic acute pancreatitis
  820. Associations of region‐specific Visceral Adiposity with subclinical atrial dysfunction and outcomes of heart failure
  821. Association of Vitamin D status with Visceral Adiposity Index and Lipid Accumulation Product Index among a Group of Iranian People
  822. Hepatic steatosis is associated with abnormal hepatic enzymes, Visceral Adiposity, altered myocardial glucose uptake measured by 18F-FDG PET/CT
  823. Does Visceral Adiposity have an effect on the survival outcomes of the patients with endometrial cancer?
  824. Dual-Energy X-Ray Absorptiometry Compared to Computed Tomography for Visceral Adiposity Assessment Among Gastrointestinal and Pancreatic Cancer …
  825. Hyperglucagonemia in youth is associated with high plasma free fatty acids, Visceral Adiposity, and impaired glucose tolerance
  826. Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma
  827. Visceral Adiposity, Pro-Inflammatory Signaling and Vasculopathy in Metabolically Unhealthy Non-Obesity Phenotype
  828. Visceral Adiposity is an independent risk factor for high intra-operative blood loss during living-donor liver transplantation; could preoperative rehabilitation and …
  829. Visceral Adiposity in patients with psoriatic arthritis and psoriasis alone and its relationship with metabolic and cardiovascular risk
  830. Association between organ damage and Visceral Adiposity index in community-dwelling elderly Chinese population: the Northern Shanghai Study
  831. Impact of a high Visceral Adiposity index on female sexual dysfunction in sexually active women? Results of a cross‐sectional study
  832. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome
  833. Lipid accumulation product (LAP) and Visceral Adiposity index (VAI) a simple and clinically useful surrogate marker for metabolic syndrome and cardiovascular …
  834. Deletion of P21-activated kinase-1 induces age-dependent increased Visceral Adiposity and cardiac dysfunction in female mice
  835. Association of new obesity indices; Visceral Adiposity index and body Adiposity index, with metabolic syndrome parameters in obese patients with or without type 2 …
  836. Response to Comment on: the Use of Visceral Adiposity Index to Predict Diabetes Remission in Low BMI Chinese Patients after Bariatric Surgery
  837. Effect of omega-3 supplementation on fatty liver and Visceral Adiposity indices in diabetic patients with non-alcoholic fatty liver disease: A randomized controlled trial
  838. Maternal adiponectin prevents Visceral Adiposity and adipocyte hypertrophy in prenatal androgenized female mice
  839. Visceral Adiposity index and triglyceride/high-density lipoprotein cholesterol ratio in hypogonadism
  840. The Predictive Value of Visceral Adiposity Index and Lipid Accumulation Index for Microalbuminuria in Newly Diagnosed Type 2 Diabetes Patients
  841. Association between Visceral Adiposity Index and hypertension among Chinese Adults: a nationwide cross-sectional study in the China Health and Nutrition Survey
  842. Evaluation of Visceral Adiposity and right ventricle diastolic and global function in patients with metabolic syndrome
  843. Piperonal attenuates Visceral Adiposity in mice fed a high‐fat diet: potential involvement of the adenylate cyclase–protein kinase A dependent pathway
  844. Visceral Adiposity syndrome and cardiometabolism
  845. Visceral Adiposity index and its association with Dietary Approaches to Stop Hypertension (DASH) diet scores among older adults: National Health and Nutrition …
  846. Visceral Adiposity Index, Triglyceride/High-Density Lipoprotein Ratio, and Lipid Accumulation Product Index to Discriminate Metabolic Syndrome Among Adult Type 1 …
  847. The assessment of life style and the Visceral Adiposity index as cardiometabolic risk factors
  848. Paradoxical prognostic implications of Visceral Adiposity for lethal cardiac events in association with impaired cardiac sympathetic innervation in chronic heart failure
  849. The role of quantitative radiological measures of Visceral Adiposity in diverticulitis
  850. Visceral Adiposity Index Score is the Better Predictor of Clinical and Coronary Angiographic Severity Assessment than Other Adiposity Indices in Patients with Acute …
  851. Maternal undernutrition and Visceral Adiposity
  852. The effects of smoking cessation on Visceral Adiposity index levels
  853. Nonalcoholic fatty liver disease in obese adolescent females is associated with multi-tissue insulin resistance and Visceral Adiposity markers
  854. Enhanced hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to diet-induced Visceral Adiposity
  855. Pediatric Visceral Adiposity index adaptation correlates with HOMA-IR, Matsuda, and transaminases
  856. Visceral Adiposity but not subcutaneous fat associated with improved outcome of patients with acute cholecystitis
  857. Impairment of primary cilia contributes to Visceral Adiposity of high fat diet‐fed mice
  858. Ablation of tanycytes of the arcuate nucleus and median eminence increases Visceral Adiposity and decreases insulin sensitivity in male mice
  859. Association of Visceral Adiposity index, lipid profile, and serum leptin with glucose intolerance risks in Iraqi obese patients: A cross-sectional study
  860. Visceral Adiposity and high adiponectin levels are associated with the prevalence of pancreatic cystic lesions
  861. Low level of adiponectin predicts the development of Nonalcoholic fatty liver disease: Is it irrespective to Visceral Adiposity index, Visceral adipose tissue thickness and …
  862. Relationship between Visceral Adiposity index and male infertility
  863. Weight Status and Visceral Adiposity Mediate the Relation between Exclusive Breastfeeding Duration and Skin Carotenoids in Later Childhood
  864. Prenatal factors associated with fetal Visceral Adiposity☆,☆☆
  865. Association of diet diversity score with Visceral Adiposity in women with polycystic ovarian syndrome
  866. Association of Visceral Adiposity and clinical outcome among patients with aldosterone producing adenoma
  867. Subtraction of subcutaneous fat to improve the prediction of Visceral Adiposity: exploring a new anthropometric track in overweight and obese youth
  868. Liver volume and hepatic Adiposity in childhood: relations to body growth and Visceral fat
  869. Visceral Adiposity and severe COVID-19 disease: application of an artificial intelligence algorithm to improve clinical risk prediction
  870. Visceral Adiposity index is not superior over anthropometric parameters with regards to inflammation in healthy adolescent girls
  871. Visceral, general, abdominal Adiposity and atherogenic index of plasma in relatively lean hemodialysis patients
  872. Measuring Visceral Adiposity
  873. P5302 Significant correlation of Visceral Adiposity and adipocytokines with arterial inflammation in genetic dyslipidaemias
  874. … Indices on Plasma Lipid Profile in Patients with Multiple Sclerosis: A Cross-Sectional Study with A Body Shape Index, Body Roundness Index, and Visceral Adiposity …
  875. Changes in the Visceral Adiposity Index (VAI) Among Obese Older Adults After a 12-Month Exercise and Diet Intervention
  876. The role of changes in subcutaneous and Visceral Adiposity, sarcopenic obesity, and myosteatosis/muscle quality in cirrhosis: How to diagnose it and its contribution to …
  877. P79 Visceral Adiposity Index is a Better Predictor of Type 2 Diabetes than Body Mass Index in the Qatari Population
  878. Predictive power of Visceral Adiposity index and model of adipose distribution in patients with non-alcoholic fatty liver disease (NAFLD)
  879. Visceral Adiposity index is associated with insulin resistance, impaired insulin secretion, and β-cell dysfunction in subjects at risk for type 2 diabetes
  880. Opportunistic use of radiological measures of Visceral Adiposity for assessment of risk of colorectal adenoma
  881. Weight Status and Visceral Adiposity Mediate the Relationship between Exclusive Breastfeeding Duration and Skin Carotenoids in Later Childhood
  882. Design and validation of a novel estimator of Visceral adipose tissue area and comparison to existing Adiposity surrogates
  883. Diet Quality and Visceral Adiposity among a Multiethnic Population of Young, Middle, and Older Aged Adults
  884. Visceral Adiposity Index and its Correlation with other Anthropometric Indicators of Obesity in a group of Bangladeshi Patients with Acute Coronary Syndrome
  885. Optimal cutoff for Visceral Adiposity index in a Venezuelan population: Results from the Maracaibo City Metabolic Syndrome Prevalence Study
  886. … Exenatide and Humalog Mix25 on Fat Distribution, Insulin Sensitivity, and β-Cell Function in Normal BMI Patients with Type 2 Diabetes and Visceral Adiposity
  887. The Association of Visceral Adiposity Index with Insulin Resistance in Adults with Prediabetes
  888. Homocysteine, Visceral Adiposity-related novel cardiometabolic risk factors, and exaggerated blood pressure response to the exercise treadmill test
  889. Relationship between glycemic control and Visceral Adiposity index among the patients with type 2 diabetes mellitus
  890. Visceral Adiposity Index and Prognostic Nutritional Index in Predicting Atrial Fibrillation after On-Pump Coronary Artery Bypass Operations: a Prospective Study
  891. Response to Letter to the Editor:“Menopausal Hormone Therapy Is Associated With Reduced and Total Visceral Adiposity: The OsteoLaus Cohort”
  892. … patients, with correlative analysis of Visceral fat, fasting insulin, and insulin resistance: A 3-year follow-up study (Mysore Visceral Adiposity in diabetes follow …
  893. Ethnic differences in Visceral Adiposity measured in early pregnancy
  894. Association between Visceral Adiposity index, hirsutism and cardiometabolic risk factors in women with polycystic ovarian syndrome: A cross-sectional study
  895. Visceral Adiposity as a predictor of survival in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy.
  896. Response: Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension (Endocrinol Metab 2017; 32: 221-9 …
  897. utility of the Visceral Adiposity index and hypertriglyceridemic waist phenotype for predicting incident hypertension (Endocrinol Metab 2017; 32: 221-9 …
  898. Obesity, Visceral Adiposity, and prostate cancer: What is the role of lifestyle interventions?
  899. Predictive value of lipid accumulation product, fatty liver index, Visceral Adiposity index for metabolic syndrome according to menopausal status
  900. Relationship between Visceral Adiposity Index, Insulin Resistance and Pancreatic Beta Cell Function According to the Prevalence of Metabolic Syndrome in Korean …
  901. The relationship between the Visceral Adiposity index and carotid atherosclerosis in different genders and age groups
  902. Visceral Adiposity is increased in patients with heart failure with preserved ejection fraction
  903. The Visceral Adiposity index predicts cardiovascular events both in cardiovascular disease patients with and in those without diabetes
  904. Can Visceral Adiposity Predict Paradoxical Prognostic Implications on Lethal Arrhythmic Events in Chronic Heart Failure Patients with Impaired Cardiac Sympathetic …
  905. Visceral Adiposity index and the degree of hepatic fibrosis and inflammation in Egyptian patients with chronic hepatitis C
  906. Atherogenic index of plasma and Visceral Adiposity index among healthcare workers in University of Benin Teaching Hospital, Benin City, Nigeria
  907. Visceral Adiposity and Pro-Inflammation: Contributions and Consequences of Immunity
  908. The use of an alternative measurement of Visceral Adiposity to evaluate endometrial cancer recurrence and survival
  909. 88 The Role of Visceral Adiposity in the Metabolic Phenotype of multi-ethnic South-East Asian population
  910. Association of new obesity indices: Visceral Adiposity index and body Adiposity index, with metabolic syndrome parameters in obese patients with or without type 2 …
  911. Letter to the Editor:“Menopausal Hormone Therapy Is Associated With Reduced Total and Visceral Adiposity: The OsteoLaus Cohort”
  912. Proportional correlates of cystatin-C with pentraxin-3, Visceral Adiposity index and atherogenicity index of plasma but not blood indices in metabolic syndrome patients …
  913. Visceral Adiposity Index was Independently Associated with Hyperuricemia in Patients with Polycystic Ovary Syndrome
  914. Visceral Adiposity Index (VAI) in Children and Adolescents with Obesity: No Association with Daily Energy Intake but Promising Tool to Identify Metabolic …
  915. P0992 PHARMACOLOGICAL UPREGULATION OF INTEGRIN-LINKED KINASE (ILK) REDUCES Visceral Adiposity IN A METABOLIC SYNDROME MICE …
  916. The Association of Visceral Adiposity Index with Insulin Resistance in Adults with Prediabetes
  917. Association between Blood Mercury Level and Visceral Adiposity in Adults
  918. Comments on the Use of Visceral Adiposity Index to Predict Diabetes Remission in Low BMI Chinese Patients after Bariatric Surgery
  919. P2595 The role of epicardial fat thickness and other parameters of Visceral Adiposity in right ventricular diastolic function in patients with metabolic syndrome
  920. SUN-415 Is ”Visceral Adiposity Index”a Better Indicator of Metabolic Syndrome in Patients with Thyroid Nodules?
  921. … Altered Metabolic Settings: Insulin-like growth factor-II in adipocyte regulation: depot-specific actions suggest a potential role limiting excess Visceral Adiposity
  922. Impact of Obesity, Visceral Adiposity and Metabolic Syndrome on Male Fertility
  923. P58 Combined effects of social relationships and Visceral Adiposity in women and men
  924. Association of Chinese Visceral Adiposity Index with Nonalcoholic Fatty Liver Disease in Individuals with type 2 Diabetes Mellitus: A Cross Sectional Study
  925. Visceral Adiposity index and atherogenic index of plasma as reliable indices to prediction of cardiovascular diseases in adults: A Cross-Sectional analysis from …
  926. Visceral Adiposity Index Outperforms Conventional Anthropometric Assessments as Predictor of Diabetes Mellitus in Elderly Chinese: A Population-Based …
  927. Correlation between the incidence of type 2 diabetes mellitus to Chinese Visceral Adiposity index in a community population of Chongqing City
  928. Visceral Adiposity index as a tool for cardiometabolic risk in obese older women
  929. Can a high Visceral Adiposity index predict female sexual dysfunction in sexually active women? Results of a cross-sectional study.
  930. Visceral Adiposity Index in prediabetes and diabetes: The Polish Norwegian Study (PONS)
  931. Short Photoperiod Lowers Visceral Adiposity and Shifts the Molecular Clock in Peromyscus leucopus
  932. Sarcopenia and Visceral Adiposity Are Not Independent Prognostic Markers for Extensive Disease of Small-Cell Lung Cancer: A Single-Centered …
  933. P1539 The Visceral Adiposity index predicts cardiovascular events both in cardiovascular disease patients with and in those without diabetes
  934. Accuracy of Waist Circumference Measurement Using the WHO versus NIH Protocol in Predicting Visceral Adiposity Using Bioelectrical Impedance Analysis …
  935. Adipocytokine, leptin, and resistin in combination with quantitative Visceral Adiposity as predictors of colorectal neoplasm: A case-control study
  936. Visceral Adiposity index is closely associated with albuminuria in the Chinese population with prediabetes: results from the REACTION study
  937. Dysfunctional epicardial adipose tissue (EAT) and maladaptive heart remodeling in patients with increased Visceral Adiposity: the ST2/IL-33 cardio-fat signaling
  938. Comparison of Visceral Adiposity Index and Chinese Visceral Adiposity Index for Coronary Artery Calcification in Korean Adults
  939. High-fat diet induced central Adiposity (Visceral fat) is associated with increased fibrosis and decreased immune cellularity of the mesenteric lymph node in mice
  940. AB0812 IS THE Visceral Adiposity INDEX ASSOCIATED WITH THE PRESENCE OF CARDIOVASCULAR RISK SCORES AND COMORBIDITY IN PSORIATIC …
  941. The relation of Visceral Adiposity index and lipid accumulation product with metabolic, anthropometric, and hormonal parameters in patients with polycystic …
  942. Emotion and Stress-related Eating is Related to the Visceral Adiposity Index among Women who are Overweight or Obese
  943. Sexual dimorphism in Visceral Adiposity measures, parameters and biomarkers of metabolic syndrome among Hausa ethnic group in Kano, Nigeria
  944. Psoriasis-Related Visceral Adiposity and Arterial Inflammation: A New Adiposity Disease Entity?
  945. DIFFERENCE OF ETHNICITY ON THE ASSOCIATION BETWEEN Visceral Adiposity AND MYOCARDIAL FUNCTION IN HEART FAILURE WITH PRESERVED …
  946. … of the Effect of Pyridoxine Hydrochloride Supplementation on Anthropometric Measurements, Body Composition, Visceral Adiposity Index and Metabolic Status …
  947. Sarcopenia and Visceral Adiposity predict poor overall survival in hepatocellular carcinoma patients after curative hepatic resection
  948. Erratum: Sleep apnoea and Visceral Adiposity in middle-aged male and female subjects (European Respiratory Journal (2013) 41 (601-609
  949. Quantification of Visceral Adiposity: evaluation of the body electrical loss analysis
  950. Rehabilitation mitigates changes in body fat%, Visceral Adiposity and lipid metabolism in the Wistar rat offspring induced by maternal vitamin B12 restriction.
  951. The Effect of 12 Weeks of Intense Interval Training on Changes in Adipose Levels and Visceral Adiposity Index in Women with Polycystic Ovary Syndrome
  952. Home Based Aerobic Training and the Changes in Adipsin Levels and Visceral Adiposity Index (VAI) in Women with Polycystic Ovary Syndrome
  953. The Effect of Aerobic Training on Lipid Accumulation Product, Visceral Adiposity, Triglyceride-Glucose and Mcauley Indices in Early Pubertal Obese/Overweight Girls
  954. Overall and Visceral Adiposity Are Associated with Incident Cardiovascular Disease among Breast Cancer Patients: Results from the B-SCANS Study
  955. Correlation of Computed Tomography Guided Visceral Adiposity & Sagittal Abdominal Diameter with Atherogenic Index of Plasma in Type 2 Diabetic Patients.
  956. 1216-P: Plasma Amino Acid Profile as a Predictive Biomarker for Visceral Adiposity in Japanese Americans
  957. Sirtuin 1 but not Osteocalcin, Correlates with Lipid Accumulation Product, Visceral Adiposity and Atherogenicity Indices in Newly Diagnosed Prediabetes-Metabolic …
  958. Circulating biomarker score for Visceral fat and risks of incident colorectal and postmenopausal breast cancer: the multiethnic cohort Adiposity phenotype study
  959. Predictive Power of Body Visceral Adiposity Index, Body Adiposity Index and Body Mass Index for Type 2 Diabetes in Qatari Population
  960. Evaluation of the Relationship Between Metabolic Syndrome, Visceral Adiposity Index and Lipid Accumulation Product in Patients with Obesity.
  961. What is the relationship between Visceral Adiposity index (VAI) and total and free sex hormones in aging polish women?
  962. Visceral Adiposity in Psoriasis is Associated with Vascular Inflammation by 18-FDG PET/CT beyond Cardiometabolic Disease Risk Factors in an …
  963. Visceral Adiposity and Muscle Composition in Heart Failure With Preserved Ejection Fraction and Association With Exercise Tolerance
  964. Visceral Adiposity Index and Atherogenic Index of Plasma as Useful Predictor of Cardiovascular Diseases Risk: Evidence From A Cohort Study in Iran
  965. Effects of metformin administration on endocrine-metabolic parameters, Visceral Adiposity and cardiovascular risk factors in children with obesity and risk markers for …
  966. miRNAs as Biomarkers of Metabolic Disorders Associated with Visceral Adiposity, a Study Protocol
  967. Visceral Adiposity and insulin resistance in the prediction of gestational diabetes mellitus in early pregnancy: a prospective observational study
  968. Visceral Adiposity is associated with altered myocardial glucose uptake measured by 18FDG-PET in 346 subjects with normal lucose tolerance, prediabetes, and type …
  969. Potential impact of exercise versus irisin on hypertension, and Visceral Adiposity in a rat model of type 2 diabetes mellitus
  970. CORONARY RISK AT Visceral Adiposity
  971. A11090 Effects of losartan on metabolic profile, Visceral Adiposity and vascular prostanoids in high-fat diet fed rats
  972. Ethnic disparities in Adiposity: focus on non-alcoholic fatty liver disease, Visceral, and generalized obesity
  973. Exploring the Influence of Diet Quality on Visceral Adiposity and Risk of Mortality from Non-communicable Diseases among Adults in the US
  974. Relationship between the Visceral Adiposity Index and neutrophil/lymphocyte ratio in patients with bipolar disorder
  975. P0749 THE ASSOCIATION OF Visceral Adiposity INDEX WITH PROGRESSION OF CHRONIC KIDNEY DISEASE
  976. 464-P: Visceral Adiposity Index Identifies Both Type 2 Diabetes Mellitus and Prediabetes Better than Established Indices of Visceral Obesity in a Pad Cohort
  977. … DISPARITIES IN THE BURDEN OF CARDIOVASCULAR DISEASES ATTRIBUTABLE TO GENERAL, ABDOMINAL AND Visceral Adiposity: RESULT FROM A …
  978. Visceral Adiposity index in patients with chronic obstructive pulmonary disease
  979. 2074-P: Significant Reduction of Visceral Adiposity in Type 2 Diabetics with Doctor-Supervised Weight Loss Program
  980. Vitamin B12 in HIV-Infected Patients with Insulin Resistance and Visceral Adiposity in a Randomized Trial of Recombinant Human Growth Hormone and …
  981. Waist circumference measurement site does not affect relationships with Visceral Adiposity and cardiometabolic r…
  982. Role of body composition and Visceral Adiposity index in breast cancer
  983. 2859The impact of Visceral Adiposity on the progression of coronary artery calcification assessed by computed tomography in Korean population
  984. Distinct impact of abdominal Visceral Adiposity on adult asthma symptoms
  985. Are Visceral Adiposity index and ultrasonographic Visceral fat thickness measurements correlated to endometrial thickness in postmenopausal women?
  986. 179-LB: Association of Leptin and Adiponectin with the Incidence of Type 2 Diabetes Independent of Visceral Adiposity and Liver Fat
  987. The Visceral Adiposity Index Predicts Cardiovascular Events Both In Cardiovascular Disease Patients With And In Those Without Diabetes
  988. Relationships of Visceral Adiposity Index and Body Shape Index with Diabetes Mellitus Risks in Chinese Adults (P21-037-19)
  989. ASSOCIATION BETWEEN THE Visceral Adiposity INDEX AND HYPERTENSION-MEDIATED ORGAN DAMAGE IN THE COMMUNITY-DWELLING ELDERLY …
  990. Visceral Adiposity Index-Predictive Index of Cardiovascular Diseases
  991. The Visceral Adiposity index-a potential marker of cardiovascular risk
  992. Natural history of impaired glucose tolerance in Japanese Americans: Change in Visceral Adiposity is associated with remission from impaired glucose tolerance to …
  993. Visceral Adiposity: A Major Predictor in Diabetes and Hypertension
  994. Evaluation of the relationship between serum ferritin and insulin resistance and Visceral Adiposity index (VAI) in women with polycystic ovary syndrome.
  995. Visceral Adiposity Index Levels in Patients with Hypothyroidism.
  996. The association of plant-based dietary patterns with Visceral Adiposity, lipid accumulation product, and triglyceride-glucose index in Iranian adults
  997. Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging
  998. A Study on Visceral Adiposity Index in patients with Acute Coronary Syndrome
  999. Visceral Adiposity IS A SIGNIFICANTLY STRONGER PREDICTOR OF DIABETES INCIDENCE IN MEN THAN IN WOMEN
  1000. Endoscopic Gastric Mucosal Devitalization (GMD) results in a similar reduction in Visceral Adiposity compared to sleeve gastrectomy (SG): A Randomized Controlled …
  1001. Clinical significance and hormonal relationships of Visceral Adiposity index (VAI) in independently living old subjects
  1002. The Relationship Between Visceral Adiposity Index and Epicardial Adipose Tissue in Patients with Type 2 Diabetes Mellitus.
  1003. A11314 Body Mass Index, Visceral Adiposity Index and Lipid Accumulation Product as Predictors of Metabolic Syndrome in Young Sudanese Adults
  1004. … in Atherosclerosis Burden and Composition Evaluated by Magnetic Resonance: A Complex Interaction Between Visceral Adiposity and Atherogenic Lipoproteins
  1005. The Visceral Adiposity Index Is a Significantly Stronger Predictor of Incident Diabetes in Men than in Women
  1006. Study of epicardial fat thickness as a marker of Visceral Adiposity in patients with hypothyroidism
  1007. Association of Visceral Adiposity Index Score with the Severity of Coronary Artery Disease in Patients with Ischemic Heart Disease
  1008. Visceral Adiposity index and atherogenic index of plasma: Simple markers of insulin resistance in type 2 diabetic patients
  1009. Automated segmentation of Visceral Adiposity in MRI in obese children
  1010. Increased Visceral Adiposity in Obese Adolescents with Hyperglycemia Compared to Normoglycemic Obese Peers
  1011. Effects of Visceral Adiposity on Glycerol Pathways in Gluconeogenesis
  1012. Relationship of subcutaneous and Visceral Adiposity to the variations of diaphragm based on computed tomography images.
  1013. Body composition and human gut microbiota analysis reveals an association between Christensenellacea family and Visceral Adiposity
  1014. Erratum: Diet Quality Predicts Visceral Adiposity and Liver Fatness: The Multiethnic Cohort Study
  1015. Visceral adipose tissue and different measures of Adiposity in different severities of diffuse idiopathic skeletal hyperostosis
  1016. Abstract P245: Economic Residential Segregation is Associated With Obesity and Visceral Adiposity in Brazilian Women: the Brazilian Longitudinal Study of Adult …
  1017. Visceral Adiposity index is independently and positively related with impaired glucose regulation in women with polycystic ovary syndrome.
  1018. IMPACT OF EXERCISE AND PHARMACOLOGIC INTERVENTIONS ON CHANGES IN Visceral Adiposity: A META-ANALYSIS OF RANDOMIZED CONTROLLED …
  1019. Toward a simple marker of hepato-Visceral Adiposity and insulin resistance: the Z-score change from weight-at-birth to BMI-in-childhood
  1020. Experimental Sleep Restriction, Energy Balance and Weight Gain: Implications for Visceral Adiposity
  1021. Dietary factors, Visceral Adiposity index (VA) and a body shape index (ABSİ) in the definition of cardiometaboli̇c risk in adult individuals
  1022. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis
  1023. A descriptive study on the relationship between Visceral Adiposity index and lipid Profile & CRP levels among non-diabetic hypertensive patients attending …
  1024. Abstract P3058: Significant Reduction of Visceral Adiposity in Hypertensive Participants of Doctor-Supervised, Intense Weight Loss Program
  1025. Visceral Adiposity index and overactive bladder in postmenopausal woman: A novel predictive risk factor
  1026. Predicting Cardiometabolic Risk From Visceral Abdominal Adiposity in Persons With Chronic Spinal Cord Injury
  1027. The Visceral Adiposity index predicts cardiovascular events both in coronary artery disease patients with and in coronary artery disease patients without diabetes
  1028. Visceral Adiposity index as a marker of metabolic risk in survivors of paediatric hematopoietic stem cell transplantation after chemotherapy-only conditioning
  1029. Visceral Adiposity in diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis subjects compared to controls
  1030. … Growth Factor II (IGF-II) in Adipocyte Regulation: Depot-Specific Actions Suggest a Potential Role Limiting Excess Visceral Adiposity. AJP-Endocrinology and …
  1031. Photoperiod Alters Visceral Adiposity and Molecular Circadian Rhythms in White‐footed Mice at Thermoneutrality
  1032. Visceral Adiposity INDEX, NON-ALCOHOLIC FATTY LIVER DISEASE AND 10-YEAR CARDIOVASCULAR DISEASE INCIDENCE: A GENDER-BASED …
  1033. PE-192: Characteristics of Asymptomatic Patients with an “Elevated Serum Alpha-Fetoprotein Level” and Its Relationship with Hepatic Steatosis and Visceral Adiposity
  1034. Associations of fetal and infant weight change with general, Visceral, and organ Adiposity at school age
  1035. Visceral and subcutaneous abdominal Adiposity and pulmonary function in 30-year-old adults: a cross-sectional analysis nested in a birth cohort
  1036. Body mass index versus Visceral Adiposity index as predictors for dyslipidemia and liver stiffness in HIV/HCV co-infected patients with liver fibrosis
  1037. … ), but not Inactive (25-OH) Vitamin D levels are inversely associated with aortic Vascular Inflammation, Non-calcified Coronary Plaque Burden and Visceral Adiposity …
  1038. Axial sarcopenia, subcutaneous, abdominal Visceral and pericardial Adiposity in heart failure with preserved and reduced ejection fraction
  1039. Abstract P363: Visceral, but Not Subcutaneous Adiposity by Computed Tomography is Associated With Increased Aortic Wall Thickness in Psoriasis Patients
  1040. Methylation of imprinted IGF2 regions is associated with total, Visceral, and hepatic Adiposity in postmenopausal women
  1041. Plasma bile acids more closely align with insulin resistance, Visceral and hepatic Adiposity than total Adiposity
  1042. Muscle wasting, Visceral and subcutaneous Adiposity, inflammation, nutritional deficiencies, and metastatic esophageal cancer (MEC) prognosis.
  1043. … fat in chickens divergently selected on bodyweight at two ages reveals novel mechanisms controlling Adiposity: validating Visceral adipose tissue as a …
  1044. Change in whole or refined grain intake and concurrent change in abdominal Visceral and subcutaneous Adiposity over 6 years of follow-up in the Framingham Third …
  1045. Prediction of type 2 diabetes mellitus using noninvasive MRI quantitation of Visceral abdominal Adiposity tissue volume
  1046. Does Inulin Ingestion Reduce Visceral Fat Adiposity? Mini Review
  1047. Genomeâ Wide Study of Subcutaneous and Visceral Adipose Tissue Reveals Novel Sexâ Specific Adiposity Loci in Mexican Americans
  1048. Glomerular filtration rate and its relationship with Visceral and subcutaneous Adiposity: a study with patients from Northeast Brazil
  1049. Genome‐Wide Study of Subcutaneous and Visceral Adipose Tissue Reveals Novel Sex‐Specific Adiposity Loci in Mexican Americans
  1050. Increased Visceral adipose tissue and altered Adiposity distribution in premenopausal lupus patients: correlation with cardiovascular risk factors
  1051. Association of two novel Adiposity indicators with Visceral fat area in type 2 diabetic patients: Novel Adiposity indexes for type 2 diabetes
  1052. Chronic Stress Burden, Visceral Adipose Tissue, and Adiposity-Related Inflammation: The Multi-Ethnic Study of Atherosclerosis
  1053. Abating abdominal Adiposity: Modifiable lifestyle risk factors for Visceral and liver fat deposition
  1054. Contribution of ultra-processed foods in Visceral fat deposition and other Adiposity indicators: Prospective analysis nested in the PREDIMED-Plus trial
  1055. Longitudinal fat mass and Visceral fat during the first 6 months after birth in healthy infants: support for a critical window for Adiposity in early life
  1056. Visceral abdominal Adiposity tissue volume quantification using noninvasive MRI in prediction of type 2 diabetes
  1057. Abstract P405: Visceral Adipose Tissue Volume is Associated With Prevalent Coronary Plaque Independent of Total Adiposity in Psoriasis
  1058. SAT-438 Visceral and Marrow Adiposity in Patients with Acromegaly; Relationships to Disease Activity, Markers of Bone Turnover, Bone Mineral Density, and …

 

Related Posts

Shopping Cart
Scroll to Top